Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1R lipoic acid[1] Lipoic acid[1] Thioctic acid 💬 --[1] 13 💬
2R(+) pramipexole dihydrochloride monohydrate[1] Pramipexole[2] Pramipexole dihydrochloride ,
Pramipexole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 2 💬
3R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride[1] Benzofuran---[1] 6 💬
4R-2487----[1] 53 💬
5R-2487 DP----[1] 46 💬
6R-3750----[1] 97 💬
7R-ATG----[1] 60 💬
8R-hIL-18BP----[1] 65 💬
9R-metHuGDNF[1] Liatermin[1] Liatermin 💬 --[1] 6 💬
10R-metHuLeptin----[1] 265 💬
11R-roscovitine----[1] 75 💬
12R-salbutamol sulphate----[1] 49 💬
13R03AC02----[1] 299 💬
14R03CC02----[1] 299 💬
15R05C B01----[1] 299 💬
16R05CB01----[1] 193 💬
17R3R01[1] R3R01---[2] 218, 222 💬
18R727----[1] 79 💬
19R788----[2] 46, 63 💬
20R788 sodium hexahydrate, RIG2-01, RIG-G----[1] 46 💬
21R788 Sodium, R788 Na, R788----[1] 46 💬
22R788, fostamatinib disodium hexahydrate (in USPI/FPI)[1] Fostamatinib[2] Fostamatinib ,
Fostamatinib disodium 💬 		[1] SYK 💬 [18] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬[1] 61 💬
23R932333----[1] 49 💬
24R935788----[4] 46, 61, 63, 66 💬
25RA101495----[1] 62 💬
26RA101495 sodium----[1] 62 💬
27RA15804589, C19061501-F, DNL788, DN2489, DN0002489----[2] 2, 13 💬
28RAAV 2/6 hIDS DONOR----[1] 19 💬
29RAAV-GAD----[1] 6 💬
30RAAV-Olig001-ASPA----[1] 307 💬
31RAAV.hPDE6A vector Pharmaceutical Form: Concentrate for solution for injection----[1] 90 💬
32RAAV1-CB-hAAT[1] rAAV1-CB-hAAT---[1] 231 💬
33RAAV1-CMV-GAA (study agent) Administration----[1] 256 💬
34RAAV1.CMV.huFollistatin344----[2] 15, 113 💬
35RAAV1.CMV.huFollistin344----[1] 113 💬
36RAAV2-ND4----[1] 302 💬
37RAAV2.5-CMV-minidystrophin (d3990)----[1] 113 💬
38RAAV2/2-ND4 VECTOR----[1] 302 💬
39RAAV2/5-hNAGLU----[1] 19 💬
40RAAV2/6 Left ZFN Vector----[1] 19 💬
41RAAV2/6 Right ZFN Vector----[1] 19 💬
42RAAV2tYF-GRK1-hRPGRco----[1] 90 💬
43RAAV2tYF-GRK1-RPGR----[1] 90 💬
44RAAV5-miHTT[1] AMT-130---[1] 8 💬
45RAAV8-Des-hMTM1----[1] 111 💬
46RAAV8-hMD1----[1] 113 💬
47RAAV9-CB6-AspA----[1] 307 💬
48RAAV9-CK8-h-µD5----[1] 113 💬
49RAAV9-hFKRPco_miR-208a----[1] 113 💬
50RAAV9.CMV.hNAGLU----[1] 19 💬
51RAAVrh74.MCK.GALGT2----[1] 113 💬
52RAAVrh74.MCK.micro-Dystrophin----[1] 113 💬
53RAB001 400 µg/kg group----[1] 71 💬
54RAB001 750 µg/kg group----[1] 71 💬
55RAB001 high dose----[1] 71 💬
56RAB001 low dose----[1] 71 💬
57RAB001 medium dose----[1] 71 💬
58Rabbit[1] Rabbit---[11] 11, 13, 49, 51, 60, 62, 65, 96, 283, 285, 326 💬
59Rabbit anti-human thymocyte immunoglobulin[1] Rabbit---[2] 13, 96 💬
60Rabbit anti-thymocyte globulin[1] Rabbit---[5] 49, 60, 65, 285, 326 💬
61Rabbit anti-thymocyte globulin (ATG)[1] Rabbit---[1] 60 💬
62Rabbit anti-thymocyte globulin (r-ATG)[1] Rabbit---[1] 60 💬
63Rabbit Anti-Thymoglobulin (rATG)[1] Rabbit---[1] 285 💬
64Rabbit antithymocyte globulin[1] Rabbit---[3] 49, 60, 96 💬
65Rabbit antithymoglobulin (ATG)[1] Rabbit---[1] 60 💬
66Rabbit ATG[1] Rabbit---[4] 60, 62, 283, 285 💬
67Rabbit ATG, (Genzyme)[1] Rabbit---[1] 60 💬
68Rabbit ATG, Cyclosporine, Levamisole[3] Cyclosporine,
Levamisole,
Rabbit		[3] Cyclosporine ,
Levamisole hydrochloride ,
Levamisole 💬 		[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 60 💬
69Rabbit ATG, Thymoglobuline (Genzyme)[1] Rabbit---[1] 60 💬
70RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN[1] Rabbit---[2] 13, 60 💬
71Rabeprazole[1] Rabeprazole[2] Rabeprazole sodium ,
Rabeprazole 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[3] 2, 6, 51 💬
72Rabeximod[1] Rabeximod---[1] 46 💬
73Raclopride[1] Raclopride---[4] 5, 6, 7, 17 💬
74RAD001----[6] 34, 67, 89, 96, 158, 228 💬
75RAD001 1mg----[1] 158 💬
76RAD001 2,5 mg----[1] 158 💬
77RAD001 5mg----[2] 89, 158 💬
78RAD001 round tablets----[1] 158 💬
79RAD001, everolimus[1] Everolimus[1] Everolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 34 💬
80RAD001: Everolimus[1] Everolimus[1] Everolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 34 💬
81RAD011----[1] 193 💬
82Radiation therapy----[3] 13, 284, 285 💬
83Radiation: 11C-MET PET/CT Imaging----[1] 53 💬
84Radiation: 11C-UCB-J----[1] 6 💬
85Radiation: 18F-FDG PET imaging----[1] 280 💬
86Radiation: 18F-FDG PET/CT Imaging----[1] 53 💬
87Radiation: 18F-fluoride PET----[1] 28 💬
88Radiation: 18F-PBR06----[1] 17 💬
89Radiation: 45 Gy external radiations----[1] 94 💬
90Radiation: [18-Fluorine] Flubatine PET Scan----[1] 6 💬
91Radiation: Cardiac PET imaging using F-18-FDG, N-13 ammonia( NH3)[1] Ammonia[1] Ammonia solution, strong 💬 --[1] 88 💬
92Radiation: cerebral MRI----[1] 6 💬
93Radiation: Chest CT scan----[1] 86 💬
94Radiation: Computed tomography lung subtraction iodine mapping[1] Iodine[1] Iodine 💬 --[1] 88 💬
95Radiation: Computerized Tomography scan----[1] 98 💬
96Radiation: Cone Beam Computed Tomography (CBCT)----[1] 51 💬
97Radiation: CT scan----[1] 75 💬
98Radiation: DaTscan----[1] 6 💬
99Radiation: delivery of 99mTc-DTPA aerosol----[1] 85 💬
100Radiation: Digital xray of jaw and teeth----[1] 46 💬
101Radiation: Diode laser 980nm&100 mWatt----[1] 56 💬
102Radiation: DOTATATE PET-CT[1] Dotatate---[1] 75 💬
103Radiation: Dual-Energy X-ray Absorptiometry Scan----[1] 86 💬
104Radiation: Endoluminal bile duct Brachytherapy----[1] 94 💬
105Radiation: Esophageal Barium Xray[1] Barium---[1] 98 💬
106Radiation: F-DOPA PET CT----[1] 75 💬
107Radiation: F18-AV-45----[1] 6 💬
108Radiation: FDG PET scan----[2] 6, 85 💬
109Radiation: FDG-PET----[1] 6 💬
110Radiation: fludeoxyglucose F 18[1] Fludeoxyglucose[1] Fludeoxyglucose F 18 💬 --[1] 34 💬
111Radiation: Fluorine F 18 Clofarabine[1] Clofarabine[1] Clofarabine 💬 [3] POLA1,
POLA2,
RRM1 💬 		[5] DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[4] 40, 46, 49, 96 💬
112Radiation: Fluoroscopy----[1] 6 💬
113Radiation: Gadopentetate Dimeglumine[1] Gadopentetic acid[2] Gadopentetate dimeglumine ,
Gadopentetic acid 💬 		--[2] 13, 34 💬
114Radiation: Gamma knife radiosurgery----[1] 77 💬
115Radiation: GSK26346763: ([18F]-FBA-A20FMDV2) IV infusion----[1] 85 💬
116Radiation: H215O PET----[2] 6, 17 💬
117Radiation: Intensity-Modulated Radiation Therapy----[1] 51 💬
118Radiation: Irradiation, Total Body----[1] 274 💬
119Radiation: Knottin tracer----[1] 85 💬
120Radiation: Low Dose Total Body Irradiation----[2] 65, 285 💬
121Radiation: low-dose total body irradiation (TBI)----[1] 60 💬
122Radiation: magnetic resonance imaging----[2] 86, 88 💬
123Radiation: Magnetic resonance imaging scanning----[1] 97 💬
124Radiation: Modified Barium Swallow Study (MBSS)[1] Barium---[1] 2 💬
125Radiation: morphological and functional MRI (fMRI)----[1] 34 💬
126Radiation: MRI----[1] 3 💬
127Radiation: MRI Contrast----[1] 46 💬
128Radiation: PET (Positron Emission Tomography) Study----[1] 17 💬
129Radiation: PET-CT----[1] 40 💬
130Radiation: PET/CT Scan----[2] 67, 84 💬
131Radiation: PET/CT Scan: Two PET scans using 1. C-11 HED and 2. N-13 Ammonia or rubidium-82[2] Ammonia,
Rubidium		[1] Ammonia solution, strong 💬 --[1] 86 💬
132Radiation: PET/MR with [11C]PBR28----[1] 6 💬
133Radiation: Planar Images----[1] 98 💬
134Radiation: Preparative Radiation Therapy----[1] 240 💬
135Radiation: radiation therapy----[5] 34, 60, 65, 284, 285 💬
136Radiation: Radiosurgical thalamotomy----[1] 6 💬
137Radiation: radiotherapy----[1] 77 💬
138Radiation: Radiotracer [11C]-CS1P1----[1] 13 💬
139Radiation: Radiotracer [11C]-DPA-713----[1] 13 💬
140Radiation: Radiotracer [12F]-FDG----[1] 13 💬
141Radiation: Rubidium PET[1] Rubidium---[1] 84 💬
142Radiation: SCANNER----[1] 166 💬
143Radiation: Single Photon Emission Computed Tomography scans----[1] 98 💬
144Radiation: Stress myocardial perfusion PET----[1] 46 💬
145Radiation: TBI----[1] 60 💬
146Radiation: Total body 200cGy----[1] 65 💬
147Radiation: Total Body Irradiation----[11] 19, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284 💬
148Radiation: Total Body Irradiation (TBI)----[2] 60, 285 💬
149Radiation: Total Body Irradiation 1200 cGy----[1] 60 💬
150Radiation: Total Body Irradiation 200 cGy----[1] 60 💬
151Radiation: Total Body Irradiation with Marrow Boosting----[2] 19, 234 💬
152Radiation: Total Lymphoid Irradiation----[1] 326 💬
153Radiation: Total Lymphoid Irradiation (TLI)----[2] 60, 118 💬
154Radiation: Total Marrow Irradiation----[1] 60 💬
155Radiation: total-body irradiation----[9] 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
156Radiation: Ultrasound of hands and feet----[1] 46 💬
157Radiation: UV-filtered light.----[1] 298 💬
158Radiation: UVB----[1] 298 💬
159Radiation: Videofluoroscopic swallow evaluation----[1] 6 💬
160Radiation: Whole-Body Dual-Energy X-ray Absorptiometry----[1] 15 💬
161Radiofrequency----[1] 46 💬
162Radiofrequency ablation----[1] 58 💬
163Radiographic Evaluation----[1] 34 💬
164Radiographs of the thoracic and lumbar spine----[1] 162 💬
165Radiolabelled OligoG CF-5/20 6% Solution----[1] 299 💬
166Radiolabelled OligoG CF-5/20 6% Solution for Nebulisation----[1] 299 💬
167Radiolabelled OligoG CF-5/20 DPI----[1] 299 💬
168Radiolabelled OligoG CF-5/20 Dry Powder for Inhalation (DPI)----[1] 299 💬
169Radiopharmaceuticals----[1] 5 💬
170Radiotracer Injection----[2] 94, 96 💬
171Radiprodil[1] Radiprodil[1] Radiprodil 💬 [1] GRIN2B 💬 [21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[3] 137, 145, 158 💬
172Radiprodil + co-administered drugs[1] Radiprodil[1] Radiprodil 💬 [1] GRIN2B 💬 [21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[2] 137, 158 💬
173Radiprodil with Carbamazepine[2] Carbamazepine,
Radiprodil		[2] Carbamazepine ,
Radiprodil 💬 		[7] GRIN2B,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[25] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Cadherin signaling, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, IgSF CAM signaling, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬[2] 137, 158 💬
174Radiprodil with Itraconazole[2] Itraconazole,
Radiprodil		[2] Itraconazole ,
Radiprodil 💬 		[1] GRIN2B 💬 [21] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[2] 137, 158 💬
175Radotinib[1] Radotinib---[1] 6 💬
176Radotinib HCl 50 mg[1] Radotinib---[1] 6 💬
177RAG-17[1] RAG-17---[1] 2 💬
178RAG-18----[1] 113 💬
179RAG-21----[1] 2 💬
180Ralenova----[1] 13 💬
181RALINEPAG[1] Ralinepag[1] Ralinepag 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
182Raloxifene[1] Raloxifene[2] Raloxifene hydrochloride ,
Raloxifene 💬 		[2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[2] 46, 77 💬
183Raloxifene hydrochloride[1] Raloxifene[2] Raloxifene hydrochloride ,
Raloxifene 💬 		[2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 46 💬
184Raltegravir[1] Raltegravir[2] Raltegravir ,
Raltegravir potassium 💬 		--[4] 13, 26, 93, 265 💬
185Raltegravir and Zidovudine[2] Raltegravir,
Zidovudine		[3] Zidovudine ,
Raltegravir ,
Raltegravir potassium 💬 		--[1] 26 💬
186Ramatroban[1] Ramatroban[1] Ramatroban 💬 [2] PTGDR,
TBXA2R 💬 		[3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬[1] 13 💬
187Ramelteon[1] Ramelteon[1] Ramelteon 💬 [2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[3] 6, 8, 46 💬
188Ramipril[1] Ramipril[1] Ramipril 💬 [1] ACE 💬 [6] Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[10] 46, 49, 57, 66, 67, 113, 218, 222, 223, 257 💬
189Ramipril or losartan[2] Losartan,
Ramipril		[3] Losartan potassium ,
Ramipril ,
Losartan 💬 		[2] ACE,
AGTR1 💬 		[19] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 223 💬
190Ramipril Tritace®, Carvedilol Carvid®,and Spironolactone Aldactone®[3] Carvedilol,
Ramipril,
Spironolactone		[4] Carvedilol ,
Ramipril ,
Spironolactone ,
Carvedilol phosphate 💬 		[7] ACE,
ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2,
NR3C2 💬 		[21] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 57 💬
191Ramosetron[1] Ramosetron[2] Ramosetron hydrochloride ,
Ramosetron 💬 		[5] HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Taste transduction 💬[1] 97 💬
192RANEXA----[1] 58 💬
193RANEXA - 750 MG - COMPRESSA A RILASCIO PROLUNGATO- USO ORALE - BLISTER (PVC/PVDC/ALLUMINIO) 60 COMPRESSE----[1] 58 💬
194RANEXA*60CPR 500MG R.P.----[1] 58 💬
195RANEXA*60CPR 750MG R.P.----[1] 58 💬
196Ranibizumab[1] Ranibizumab[1] Ranibizumab 💬 [1] VEGFA 💬 [24] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[4] 34, 166, 227, 301 💬
197Ranibizumab injection (0.5 mg)[1] Ranibizumab[1] Ranibizumab 💬 [1] VEGFA 💬 [24] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[2] 166, 301 💬
198RANIDIL - 50 MG/5 ML SOLUZIONE INIETTABILE PER USO ENDOVENOSO 10 FIALE----[1] 28 💬
199RANITIDINA----[1] 28 💬
200Ranitidine[1] Ranitidine[3] Ranitidine ,
Ranitidine hydrochloride ,
Ranitidine bismuth citrate 💬 		[1] HRH2 💬 [4] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[2] 13, 65 💬
201RANKL/OPG ratio----[1] 49 💬
202Ranolazina Ranexa----[1] 58 💬
203Ranolazine[1] Ranolazine[2] Ranolazine ,
Ranolazine hydrochloride 💬 		--[8] 2, 57, 58, 86, 96, 97, 113, 114 💬
204Ranolazine 1000 MG[1] Ranolazine[2] Ranolazine ,
Ranolazine hydrochloride 💬 		--[1] 2 💬
205Ranolazine 1000 mg PR tablets[1] Ranolazine[2] Ranolazine ,
Ranolazine hydrochloride 💬 		--[1] 58 💬
206Ranolazine 500 MG[1] Ranolazine[2] Ranolazine ,
Ranolazine hydrochloride 💬 		--[1] 2 💬
207Ranolazine 500 mg PR tablets[1] Ranolazine[2] Ranolazine ,
Ranolazine hydrochloride 💬 		--[1] 58 💬
208Ranolazine 750 mg PR tablets[1] Ranolazine[2] Ranolazine ,
Ranolazine hydrochloride 💬 		--[1] 58 💬
209Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die[1] Ranolazine[2] Ranolazine ,
Ranolazine hydrochloride 💬 		--[1] 58 💬
210RAPA-501 Autologous T stem cells----[1] 2 💬
211Rapamicina tópica al 1% y excipiente----[1] 157 💬
212Rapamune----[8] 2, 60, 66, 67, 84, 158, 278, 280 💬
213RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE----[1] 2 💬
214Rapamune 0.5 mg coated tablets----[1] 280 💬
215Rapamune 1 mg/ ml solution buvable----[1] 278 💬
216Rapamune 1 mg/ml oral solution----[3] 137, 158, 280 💬
217Rapamune 1 mg/ml solución oral----[1] 158 💬
218Rapamune 1mg tablets----[1] 67 💬
219Rapamune 1mg/ml oral solution----[1] 137 💬
220RAPAMUNE*100CPR RIV 1MG----[1] 67 💬
221RAPAMUNE*30CPR RIV 1MG----[1] 67 💬
222RAPAMUNE*30CPR RIV 2MG----[1] 67 💬
223Rapamycin[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[13] 2, 15, 49, 51, 53, 60, 63, 67, 96, 158, 256, 278, 279 💬
224Rapamycin cream, topical, 0.5%, 1.0% w/w[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 158 💬
225Rapamycin dosage----[1] 278 💬
226Rapamycin, sirolimus[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [52] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[2] 89, 158 💬
227Rapamycin-calcitriol combination[1] Calcitriol[1] Calcitriol 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 158 💬
228Rapcabtagene autoleucel----[5] 43, 44, 46, 49, 51 💬
229Rapcabtagene autoleucel (YTB323)----[1] 13 💬
230Rapeglinide----[1] 299 💬
231Rapeseed oil----[1] 79 💬
232Rapid Dose Titration Group of Subcutaneous Treprostinil[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
233Rapid-tapering glucocorticoids + Inebilizumab[1] Inebilizumab[1] Inebilizumab 💬 [1] CD19 💬 [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬[1] 13 💬
234Raptiva----[3] 37, 49, 53 💬
235Raptiva 100 mg/ml powder and solvent for solution for injection----[9] 11, 13, 46, 48, 53, 61, 95, 96, 221 💬
236RAS 2410----[1] 66 💬
237RAS inhibitor----[1] 66 💬
238Rasagilin----[2] 5, 6 💬
239RASAGILINA MESILATO----[2] 6, 17 💬
240Rasagilina mesilato (12 weeks)----[1] 6 💬
241Rasagiline[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[4] 2, 5, 6, 17 💬
242Rasagiline 0.75 mg[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
243Rasagiline 1 mg capsule[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
244Rasagiline 1mg tablet[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
245Rasagiline 2 mg tablet[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
246RASAGILINE MESILATE[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[3] 2, 5, 6 💬
247RASAGILINE MESYLATE[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[2] 6, 17 💬
248Rasagiline mesylate 1.0 mg[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
249Rasagiline mesylate plus Mirapex[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
250Rasagiline mesylate with Levodopa[2] Levodopa,
Rasagiline		[4] Levodopa ,
Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[6] DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
MAOB 💬 		[21] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6 💬
251Rasagiline mesylate with Requip[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
252Rasagiline Tablets[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAOB 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
253RASi plus carvedilol[1] Carvedilol[2] Carvedilol ,
Carvedilol phosphate 💬 		[5] ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2 💬 		[15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 57 💬
254Raspberry[1] Raspberry[1] Raspberry 💬 --[1] 97 💬
255RATG----[2] 13, 51 💬
256Ravagalimab[1] Ravagalimab[1] Ravagalimab 💬 [1] CD40 💬 [17] Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬[3] 46, 53, 97 💬
257RAVICTI----[2] 7, 251 💬
258RAVICTI 1.1 g/ml----[1] 7 💬
259Ravicti low dose----[1] 299 💬
260RAvPAL-PEG----[1] 240 💬
261RAvPAL-PEG 0.001 mg/kg----[1] 240 💬
262RAvPAL-PEG 0.003 mg/kg----[1] 240 💬
263RAvPAL-PEG 0.01 mg/kg----[1] 240 💬
264RAvPAL-PEG 0.03 mg/kg----[1] 240 💬
265RAvPAL-PEG 0.1 mg/kg----[1] 240 💬
266RAVULIZUMAB[1] Ravulizumab[1] Ravulizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[8] 2, 11, 13, 50, 62, 66, 109, 224 💬
267Raxone----[2] 113, 302 💬
268RAXONE - 150 MG- COMPRESSE RIVESTITE CON FILM- USO ORALE- FLACONE (HDPE)- 180 COMPRESSE----[1] 113 💬
269RAY121----[4] 48, 50, 63, 162 💬
270RAYOS----[1] 49 💬
271RAYOS (delayed-release prednisone)[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 46 💬
272RbATG----[2] 51, 96 💬
273RC18 160 mg----[2] 13, 53 💬
274RC18 160 mg plus MTX----[1] 46 💬
275RC18 160 mg plus standard therapy----[1] 49 💬
276RC18 160mg----[3] 11, 13, 66 💬
277RC18 240 mg----[2] 11, 53 💬
278RC18 240 mg plus standard therapy----[1] 49 💬
279RC18 240mg----[2] 13, 66 💬
280RC18 80 mg plus standard therapy----[1] 49 💬
281Rcombinant Human Parathyroid Hormone [rhPTH(1-84)][1] Parathyroid hormone[1] Parathyroid hormone 💬 [2] PTH1R,
PTH2R 💬 		[4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
282RCT1100[1] RCT1100---[1] 340 💬
283RCT2100----[1] 299 💬
284RCTB-401----[2] 96, 97 💬
285RD06-04[1] RD06-04---[3] 49, 51, 53 💬
286RD06-04 CART Cell Injection[1] RD06-04---[3] 49, 51, 53 💬
287RD06-04 Cells injection[1] RD06-04---[1] 49 💬
288RD06-05 CAR-T Cell Injection----[3] 49, 51, 53 💬
289RD06-05 CART Cell Infusion----[2] 96, 97 💬
290RD06-05 CART Cell Injection----[3] 13, 51, 223 💬
291RD13-02[1] RD13-02---[1] 60 💬
292RDD to Palynziq----[1] 240 💬
293RDP58[1] RDP58---[1] 97 💬
294RE-021----[3] 66, 218, 222 💬
295RE-021 (Sparsentan)[1] Sparsentan[1] Sparsentan 💬 [2] AGTR1,
EDNRA 💬 		[18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 222 💬
296RE-024----[1] 121 💬
297Reactive Corticosteroid Taper Regimen----[1] 251 💬
298Reagila----[1] 21 💬
299Real word drugs----[1] 266 💬
300Rebamipide[1] Rebamipide[1] Rebamipide 💬 --[5] 46, 53, 56, 97, 271 💬
301Rebamipide mouthwash[1] Rebamipide[1] Rebamipide 💬 --[1] 56 💬
302REBIF----[1] 13 💬
303Rebif (IFN beta-1a subcutaneous three times per week)----[1] 13 💬
304Rebif (IFN ß-1a subcutaneous three times per week)----[1] 13 💬
305Rebif (IFNbeta-1-a, Merck Europe B.V.)----[1] 13 💬
306Rebif (IFNß-1-a, Merck Europe B.V.)----[1] 13 💬
307Rebif (interferon beta 1a)----[1] 13 💬
308Rebif (Interferon beta-1a)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
309Rebif (interferon beta-1a), Merck Serono Europe Ltd[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
310REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE----[1] 13 💬
311Rebif 22----[1] 13 💬
312Rebif 22 micrograms----[1] 13 💬
313Rebif 22 y 44 mcg----[1] 13 💬
314Rebif 22®----[1] 13 💬
315Rebif 44----[1] 13 💬
316Rebif 44 microgrammi/0.5ml soluzione iniettabile in cartuccia----[1] 13 💬
317REBIF 44 microgramos solución inyectable----[1] 13 💬
318REBIF 44 microgramos solución inyectable en jeringa precargada----[1] 13 💬
319Rebif 44 micrograms----[1] 13 💬
320Rebif 44 micrograms solution for injection----[1] 13 💬
321Rebif 44 micrograms solution for injection in pre-filled syringe----[1] 13 💬
322Rebif 44 µg----[1] 13 💬
323Rebif 44®----[1] 13 💬
324Rebif 8,8 µg, Rebif 22µg----[1] 13 💬
325Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack----[1] 13 💬
326Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack.----[1] 13 💬
327Rebif New Formulation + ibuprofen PRN[1] Ibuprofen[5] Ibuprofen ,
Ibuprofen aluminum ,
Ibuprofen lysine ,
Ibuprofen sodium ,
Ibuprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
328Rebif New Formulation + prophylactic Ibuprofen[1] Ibuprofen[5] Ibuprofen ,
Ibuprofen aluminum ,
Ibuprofen lysine ,
Ibuprofen sodium ,
Ibuprofen sodium 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
329Rebif New Formulation 44mcg multidose cartridge----[1] 13 💬
330Rebif New Formulation Non Titrated----[1] 13 💬
331Rebif New Formulation Titrated----[1] 13 💬
332REBIF SC 12SIR 12000000UI44MCG----[1] 13 💬
333REBIF SC 12SIR 6000000UI 22MCG----[1] 13 💬
334REBIF*SC 12SIR 12000000UI44MCG----[1] 13 💬
335REBIF*SC 12SIR 6000000UI 22MCG----[1] 13 💬
336Rebif®----[1] 13 💬
337Rebif® (clone 484-39)----[1] 13 💬
338Rebif® New Formulation----[1] 13 💬
339Rebif® New Formulation (IFN-beta-1a, RNF)----[1] 13 💬
340Rebif® new formulation (RNF)----[1] 13 💬
341Rebif® New Formulation (RNF) using RebiSmartTM----[1] 13 💬
342Rebisufligene etisparvovec[1] Rebisufligene etisparvovec---[1] 19 💬
343Reblozyl----[1] 282 💬
344REC-2282----[1] 34 💬
345Rec-h-FGF19----[1] 94 💬
346Received hormone maintenance therapy----[1] 96 💬
347Recifercept[1] Recifercept[1] Recifercept 💬 [1] FGFR3 💬 [12] Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[1] 276 💬
348Recifercept (proposed INN)[1] Recifercept[1] Recifercept 💬 [1] FGFR3 💬 [12] Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[1] 276 💬
349Recombiant human Desoxyribonuclease ( rhDNase)[1] Desoxyribonuclease---[1] 299 💬
350Recombinant A Disintegrin and Metalloproteinase Thrombospondin Type-1 Motifs 13----[1] 64 💬
351Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1----[1] 64 💬
352Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs----[1] 64 💬
353Recombinant A Disintegrin and Metalloproteinase with Thrombospondin Type-1 Motifs 13----[1] 64 💬
354Recombinant A Disintegrin And Metalloproteinase with Thrombospondin Type-1 Motifs 13 (rADAMTS13)[1] Apadamtase alfa[2] Apadamtase alfa ,
Apadamtase alfa and cinaxadamtase alfa 💬 		[1] ADAMTS13 💬 [1] Platelet activation 💬[1] 64 💬
355Recombinant A Disintegrin And Metalloproteinase with Thrombospondin Type-1 Motifs 13 (rADAMTS13) Product Code: TAK-755Pharmaceutical Form: Powder and solvent for solution for injectionINN or Proposed INN: Apadamtase alfaCurrent Sponsor code: TAK-755Other descriptive name: BAX930 - RECOMBINANT HUMAN ADAMTS13Concentration unit: IU international unit(s)Concentration type: equalConcentration number: 1500-Pharmaceutical form of the placebo: Powder and solution for solution for injectionRoute of administration of the placebo: Intravenous use----[1] 64 💬
356Recombinant AAV vector serotype 2 containing the human wild type mitochondrial ND4 gene----[1] 302 💬
357Recombinant AAV vector serotype 2 containing the human wild typemitochondrial ND4 gene----[1] 302 💬
358Recombinant AAV-9 vector expressing the human progranulin protein[1] Progranulin---[1] 127 💬
359Recombinant ADAMTS13----[1] 64 💬
360RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR EXPRESSING THE HUMAN ALPHA-1-ANTITRYPSIN GENE----[1] 231 💬
361Recombinant adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene----[1] 90 💬
362Recombinant Adeno-Associated Viral vector, serotype 2 (rAAV2/2) containing the human wild-type mitochondrial NADH Dehydrogenase 4 gene (ND4)[1] NADH---[1] 302 💬
363Recombinant Adeno-associated virus 2/6 vector encoding the cDNA for human alpha galactosidase A----[1] 19 💬
364Recombinant adeno-associated virus administration----[1] 169 💬
365Recombinant alpha-galactosidase A----[1] 19 💬
366Recombinant antihumanized anti-human monoclonal antibody directed against the IL-6R----[1] 107 💬
367Recombinant DNA-derived human growth hormone----[1] 187 💬
368RECOMBINANT FACTOR FC FUSION PROTEIN----[2] 46, 49 💬
369Recombinant Factor XIII----[1] 288 💬
370Recombinant Factor XIII (rFXIII)----[1] 97 💬
371Recombinant form of human nerve growth factor produced in Escherichia Coli.[2] Escherichia coli,
Nerve Growth Factor		---[1] 53 💬
372Recombinant granulocyte - colony stimulating factor----[1] 39 💬
373Recombinant growth hormone----[1] 96 💬
374Recombinant Growth Hormone, Genotropin (Pfizer)----[1] 78 💬
375Recombinant Herpes Zoster Vaccine (RZV)----[7] 46, 49, 50, 51, 53, 56, 107 💬
376RECOMBINANT HUMAN ?-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN----[1] 256 💬
377Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (NEOGAA)[2] Avalglucosidase alfa,
Mannose		[2] Avalglucosidase alfa ,
Demannose 💬 		[1] GAA 💬 [3] Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬[1] 256 💬
378Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan Avalglucosidase Alfa (NeoGAA)[2] Avalglucosidase alfa,
Mannose		[2] Avalglucosidase alfa ,
Demannose 💬 		[1] GAA 💬 [3] Galactose metabolism, Lysosome biogenesis, Starch and sucrose metabolism 💬[1] 256 💬
379Recombinant human acid alfa-glucosidase (rhGAA)----[1] 256 💬
380Recombinant human acid alpha-glucosidase (rhGAA)----[1] 256 💬
381Recombinant human acid sphingomyelinase----[1] 19 💬
382RECOMBINANT HUMAN ACID SPHINGOMYELINASE (rhASM)----[1] 19 💬
383RECOMBINANT HUMAN ALFA-GLUCOSIDASE CONJUGATED WITH SYNTHETIC BISMANNOSE-6-PHOSPHATE-MAN6 GLYCAN----[1] 256 💬
384Recombinant human alpha B-crystallin----[1] 13 💬
385Recombinant human alpha galactosidase A (agalsidase beta)[1] Agalsidase beta[1] Agalsidase beta 💬 [1] GLA 💬 [5] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬[1] 19 💬
386Recombinant human alpha-galactosidase----[1] 19 💬
387Recombinant human alpha-galactosidase A (agalsidase beta)[1] Agalsidase beta[1] Agalsidase beta 💬 [1] GLA 💬 [5] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬[1] 19 💬
388Recombinant human alpha-galactosidase abbreviated as r-h-alpha-GAL----[1] 19 💬
389Recombinant human alpha-mannosidase----[1] 19 💬
390Recombinant Human Alpha-N-Acetylglucosaminidase (rhNAGLU)----[1] 19 💬
391Recombinant Human Angiotensin-converting enzyme 2 (ACE2), APN01----[1] 86 💬
392Recombinant human anti IL-22 monoclonal antibody IgG1----[1] 46 💬
393Recombinant human anti-GDF-8 antibody----[1] 113 💬
394Recombinant Human Apolipoprotein----[1] 79 💬
395Recombinant Human Apolipoprotein A-I----[1] 79 💬
396Recombinant Human Apolipoprotein A-I/Phospholipids Complex----[1] 79 💬
397Recombinant human apolipoprotein a1----[1] 79 💬
398RECOMBINANT HUMAN ARYLSULFATASE A[1] Recombinant human arylsulfatase A---[1] 19 💬
399Recombinant Human Arylsulfatase A (rhASA)[1] Recombinant human arylsulfatase A---[1] 19 💬
400Recombinant Human Arylsulfatase A (rhASA,[1] Recombinant human arylsulfatase A---[1] 19 💬
401Recombinant human Arysulfatase B, recombinant human N-acetylgalactosamine 4-sulfatase----[1] 19 💬
402RECOMBINANT HUMAN BETA GLUCURONIDASE----[1] 19 💬
403Recombinant human beta-glucuronidase----[1] 19 💬
404Recombinant human beta-glucuronidase (rhGUS)----[1] 19 💬
405Recombinant human betaglucuronidase----[1] 19 💬
406Recombinant human brain natriuretic peptide (rhBNP)----[1] 215 💬
407Recombinant human C1 esterase inhibitor----[1] 65 💬
408Recombinant Human C1 Inhibitor[1] Conestat alfa[1] Conestat alfa 💬 [3] C1R,
C1S,
KLKB1 💬 		[5] Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 65 💬
409Recombinant human Cerebral Dopamine Neurotrophic Factor[1] Dopamine[2] Dopamine hydrochloride ,
Dopamine 💬 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
410Recombinant human derived macrophage-targeted beta-Glucocerebrosidase----[1] 19 💬
411Recombinant human derived macrophage-targeted ß-Glucocerebrosidase----[1] 19 💬
412Recombinant Human DNase (Pulmozyme)----[1] 299 💬
413RECOMBINANT HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 FUSED TO THE FC FRAGMENT OF IGG1----[1] 166 💬
414Recombinant Human Erythropoietin[1] Erythropoietin[4] Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 13 💬
415Recombinant human erythropoietin(rhEPO)[1] Erythropoietin[4] Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 2 💬
416Recombinant human glucerebrosidase----[1] 19 💬
417Recombinant human glucocerebrosidase----[1] 19 💬
418Recombinant Human Glucocerebrosidase (prGCD)[1] Taliglucerase alfa[1] Taliglucerase alfa 💬 [1] GBA1 💬 [4] Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
419RECOMBINANT HUMAN GROWTH HORMON----[1] 193 💬
420Recombinant human growth hormone----[4] 77, 193, 265, 276 💬
421Recombinant Human Growth Hormone (rhGH) Injection----[1] 193 💬
422Recombinant human growth hormone + rosiglitazone[1] Rosiglitazone[2] Rosiglitazone maleate ,
Rosiglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 265 💬
423Recombinant human heparan N-sulfatase----[1] 19 💬
424Recombinant human heparan N-sulfatase (rhHNS)----[1] 19 💬
425Recombinant human heparan N-sulfatase [rhHNS]----[1] 19 💬
426Recombinant human heparan Nsulfatase (rhHNS)----[1] 19 💬
427Recombinant human hyaluronidase[1] Hyaluronidase[3] Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--[1] 65 💬
428Recombinant Human Hyaluronidase (rHuPH20)[1] Hyaluronidase[3] Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--[1] 65 💬
429Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV)[1] Hyaluronidase[3] Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--[1] 65 💬
430Recombinant human hyaluronidase + immune globulin intravenous[1] Hyaluronidase[3] Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--[1] 65 💬
431Recombinant human hyaluronidase PH20[1] Hyaluronidase[3] Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		--[1] 28 💬
432Recombinant human IFN beta----[1] 13 💬
433Recombinant human IGF-1----[1] 299 💬
434Recombinant Human Insulin Growth Factor 1 (rhIGF-1)----[1] 156 💬
435Recombinant human Insulin-like Growth Factor----[1] 96 💬
436Recombinant human interferon beta[1] Human interferon beta[1] Interferon beta 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
437Recombinant human interferon beta-1a[2] Human interferon beta,
Interferon beta-1a		[2] Interferon beta ,
Interferon beta-1a 💬 		[2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 26 💬
438Recombinant Human Interleukin-11 (rhIL-11)----[2] 96, 97 💬
439Recombinant human interleukin-2 (rhIL-2)[1] Human interleukin-2[1] Celmoleukin 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 35 💬
440Recombinant human interleukin-7[1] Interleukin-7---[1] 25 💬
441Recombinant human lysosomal acid lipase----[1] 19 💬
442Recombinant human lysosomal acid lipase (rhLAL)----[1] 19 💬
443Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA)[1] Cholesterol[1] Cholesterol 💬 --[1] 19 💬
444Recombinant human lysosomal acid lipase (rhLAL), esterase, cholesterol (human gene LIPA), lysosomal acid lipase (human gene LIPA)[1] Cholesterol[1] Cholesterol 💬 --[1] 19 💬
445Recombinant human lysosomal alpha-mannosidase----[1] 19 💬
446Recombinant human Mab of IgG4 subtype----[1] 46 💬
447Recombinant human monoclonal antibody----[1] 46 💬
448Recombinant human monoclonal antibody to human IL-1Beta of the IgG1/K class----[3] 106, 107, 108 💬
449Recombinant human monoclonal antibody to Il-17 of the IgG1-k-class----[1] 271 💬
450Recombinant human monoclonal antibody to inerleukin-1beta of the IgG1-K-class----[1] 46 💬
451Recombinant human monoclonal antibody to interleukin-1beta of the IgG1-Kappa-class----[1] 46 💬
452Recombinant human N-acetylgalactosamine 4-sulfatase----[1] 19 💬
453Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110----[1] 19 💬
454Recombinant human N-acetylgalactosamine 6-sulfatase, BMN 110 drug substance----[1] 19 💬
455Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS)----[1] 19 💬
456Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110----[1] 19 💬
457Recombinant human N-acetylgalactosamine-6-sulfatase, BMN 110 drug substance----[1] 19 💬
458Recombinant human Nacetylgalactosamine-----[1] 19 💬
459RECOMBINANT HUMAN NERVE GROWTH FACTOR (RHNGF)[1] Nerve Growth Factor---[1] 90 💬
460RECOMBINANT HUMAN PARATHYROID HORMONE (1-84)[1] Parathyroid hormone[1] Parathyroid hormone 💬 [2] PTH1R,
PTH2R 💬 		[4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
461Recombinant Human Parathyroid Hormone [rhPTH(1-84)][1] Parathyroid hormone[1] Parathyroid hormone 💬 [2] PTH1R,
PTH2R 💬 		[4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
462Recombinant human Pentraxin-2----[1] 85 💬
463Recombinant human Pentraxin-2 (PRM-151)----[1] 85 💬
464Recombinant human porphobilinogen deaminase (Porphozym)[1] Porphobilinogen---[1] 254 💬
465Recombinant Human Proteoglycan 4----[1] 53 💬
466Recombinant human somatotropin[1] Somatotropin[1] Somatropin 💬 [1] GHR 💬 [6] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 236 💬
467Recombinant Human Thrombopoietin[2] Recombinant Human Thrombopoietin,
Thrombopoietin		---[2] 60, 63 💬
468Recombinant human thrombopoietin (rh-TPO)[2] Recombinant Human Thrombopoietin,
Thrombopoietin		---[1] 63 💬
469Recombinant Human Thrombopoietin (rhTPO)[2] Recombinant Human Thrombopoietin,
Thrombopoietin		---[1] 63 💬
470Recombinant Human Thrombopoietin(rhTPO)[2] Recombinant Human Thrombopoietin,
Thrombopoietin		---[1] 63 💬
471Recombinant Human TPO----[1] 63 💬
472Recombinant human tripeptidyl peptidase-1[1] Cerliponase alfa[1] Cerliponase alfa 💬 [1] TPP1 💬 [1] Lysosome biogenesis 💬[1] 19 💬
473RECOMBINANT HUMAN TRIPEPTIDYL PEPTIDASE-1 (RHTPP1)[1] Cerliponase alfa[1] Cerliponase alfa 💬 [1] TPP1 💬 [1] Lysosome biogenesis 💬[1] 19 💬
474Recombinant humanised anti-human monoclonal antibody directed against the IL-6R----[1] 46 💬
475Recombinant humanized anti-alpha 4 integrin antibody----[1] 13 💬
476Recombinant humanized anti-CD20 monoclonal antibody----[1] 13 💬
477Recombinant humanized anti-human Interleukin 6-Receptor (IL-6R) monoclonal----[1] 46 💬
478Recombinant humanized anti-human Interleukin 6-Receptor (IL-6R) monoclonal antibody----[1] 46 💬
479Recombinant humanized anti-human Interleukin-6[1] Human interleukin-6---[1] 46 💬
480Recombinant humanized anti-human Interleukin-6 Receptor (IL-6R) monoclonal antibody[1] Human interleukin-6---[1] 46 💬
481Recombinant humanized anti-human monoclonal antibody directed against the IL-6R----[3] 46, 51, 107 💬
482Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection----[1] 46 💬
483Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4 mg/kg, q2w----[1] 331 💬
484Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg,q3w----[1] 331 💬
485Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 6 mg/kg, q2w----[1] 331 💬
486Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 6 mg/kg, q3w----[1] 331 💬
487Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 8 mg/kg, q2w----[1] 331 💬
488Recombinant humanized IgG4 monoclonal antibody----[1] 61 💬
489Recombinant humanized IL-17A Monoclonal Antibody(JS005)----[1] 271 💬
490Recombinant humanized monoclonal antibody omalizumab to IgE[1] Omalizumab[1] Omalizumab 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 299 💬
491Recombinant humanized monoclonal antibody specific for human IL-5----[1] 44 💬
492Recombinant humanized monoclonal antibody to IL-6R----[1] 46 💬
493Recombinant humanized monoclonal antibody: IgG4 (heavy chain)----[1] 61 💬
494Recombinant interferon alfa[1] Interferon alfa[1] Interferon alfa 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[2] 26, 28 💬
495RECOMBINANT INTERFERON BE----[1] 13 💬
496RECOMBINANT INTERFERON BETA-1B[1] Interferon beta-1b[1] Interferon beta-1b 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
497Recombinant LCAT----[1] 259 💬
498Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)----[1] 60 💬
499Recombinant microbial lipase----[1] 298 💬
500Recombinant Microbial Lipase SLV339----[1] 298 💬
501RECOMBINANT NEISSERIA----[1] 11 💬
502RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E.COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE[1] Aluminium---[1] 11 💬
503RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN----[1] 11 💬
504RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN----[2] 11, 13 💬
505Recombinant porcine coagulation factor VIII (B domain deleted)----[1] 288 💬
506Recombinant porcine coagulation factor VIII (B-domain deleted)----[1] 288 💬
507Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN6 gene----[1] 19 💬
508Recombinant Somatropin----[1] 193 💬
509Recombinant TNF-a receptor: IgG Fc fusion protein----[2] 46, 271 💬
510Recombinant truncated SPINT2 protease inhibitor----[1] 299 💬
511Recombinant zoster vaccine----[2] 13, 49 💬
512Recombinant-methionyl human glial cell line-derived neurotrophic factor----[1] 6 💬
513Rectal Biopsy----[1] 299 💬
514Rectal biopsy taken opportunistically during endoscopy procedure for other reasons.----[1] 299 💬
515Rectal dialysis----[1] 97 💬
516Rectal tacrolimus[1] Tacrolimus[2] Tacrolimus ,
Tacrolimus 💬 		[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 97 💬
517Rectosigmoidoscopy----[1] 97 💬
518Red Blood Cell Transfusions (RBCT)----[1] 60 💬
519Red Blood Cell Zn----[1] 299 💬
520Redasemtide[1] Redasemtide---[1] 36 💬
521Reditux----[1] 46 💬
522Reduced dose of cyclophosphamide combined with standard immunosuppressive therapy[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 60 💬
523Reduced Glutathione[1] Glutathione[1] Glutathione 💬 --[2] 6, 299 💬
524Reduced Glutathione 100mg[1] Glutathione[1] Glutathione 💬 --[1] 6 💬
525Reduced Glutathione 200mg[1] Glutathione[1] Glutathione 💬 --[1] 6 💬
526Reduced glutathione sodium salt[1] Glutathione[1] Glutathione 💬 --[1] 299 💬
527Reduced intensity allogeneic hematopoietic stem cell transplantation----[1] 51 💬
528Reduced Intensity Allogeneic Transplant----[2] 49, 51 💬
529Reduced Intensity Conditioning----[2] 19, 65 💬
530Reduced Intensity Preparative Regimen----[3] 62, 65, 284 💬
531Reduced Toxicity Ablative Regimen----[3] 62, 65, 284 💬
532Reduced-dose conditioning regimen containing TBI in hematopoietic stem cell transplantation treating elderly patients with aplastic anemia----[1] 60 💬
533REF CRUZADA PEI Nº 12-088----[1] 274 💬
534Reference capsule GDC-0134[1] GDC-0134---[1] 2 💬
535Reference Medicinal Product----[1] 46 💬
536Reference product----[1] 46 💬
537Refresh Endura----[1] 53 💬
538Regadenoson[1] Regadenoson[2] Regadenoson ,
Regadenoson 💬 		[1] ADORA2A 💬 [8] Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[2] 57, 58 💬
539REGE pro dressing----[1] 36 💬
540REGEND001----[1] 85 💬
541REGEND007 Cell Therapy----[1] 85 💬
542Regimen Selection Phase Group 1 (COMPLETED)----[1] 113 💬
543Regimen Selection Phase Group 2----[1] 113 💬
544Regimen Selection Phase Group 3----[1] 113 💬
545REGN 727----[1] 79 💬
546REGN13335----[1] 86 💬
547REGN1500----[1] 79 💬
548REGN1500 250 mg SC/15 mg/kg IV/450 mg SC----[1] 79 💬
549REGN2477----[1] 272 💬
550REGN2477+REGN1033----[1] 15 💬
551REGN3918----[2] 11, 62 💬
552REGN4461----[1] 265 💬
553REGN475/SAR164877----[1] 298 💬
554REGN7257----[1] 60 💬
555REGN727----[1] 79 💬
556REGN727 (SAR236553)----[1] 79 💬
557REGN727/SAR236553----[1] 79 💬
558REGN88----[1] 46 💬
559Regular Novolin R----[1] 6 💬
560Regular treatment----[1] 97 💬
561Regulatory T cells----[2] 95, 97 💬
562Reh-acteoside[1] Acteoside---[1] 66 💬
563Relacorilant[1] Relacorilant[1] Relacorilant 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 75 💬
564RelacorilantCAS Number: 1496510-51-0Current Sponsor code: CORT125134 Other descriptive name: (R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4YL)SULFONYL)4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONEConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 100-----[1] 75 💬
565Relaxin----[1] 51 💬
566RELDESEMTIV[1] Reldesemtiv[1] Reldesemtiv 💬 [3] TNNC2,
TNNI2,
TNNT3 💬 		[3] Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬[2] 2, 3 💬
567Reldesemtiv 150 mg[1] Reldesemtiv[1] Reldesemtiv 💬 [3] TNNC2,
TNNI2,
TNNT3 💬 		[3] Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬[1] 3 💬
568Reldesemtiv 450 mg[1] Reldesemtiv[1] Reldesemtiv 💬 [3] TNNC2,
TNNI2,
TNNT3 💬 		[3] Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬[1] 3 💬
569Relebactam[1] Relebactam[1] Relebactam 💬 --[1] 299 💬
570Relma-cel----[2] 49, 51 💬
571Relovade----[1] 63 💬
572Remestemcel-L[1] Remestemcel-L[1] Remestemcel-L 💬 --[2] 96, 97 💬
573Remibrutinib[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[3] 11, 13, 53 💬
574Remibrutinib (Blinded)[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 11, 13 💬
575Remibrutinib (Open Label)[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[2] 11, 13 💬
576Remibrutinib oral treatment[1] Remibrutinib[1] Remibrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 13 💬
577REMICADE----[9] 46, 49, 56, 84, 85, 96, 97, 223, 271 💬
578Remicade (anti tumor necrosis factor inhibitor)----[1] 40 💬
579REMICADE (INFLIXIMAB)[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[3] 46, 96, 97 💬
580REMICADE - 100 MG POLVERE PER CONCENTRATO PER INFUSIONE ENDOVENOSA 1 FLACONE VETRO 20 ML USO EV----[1] 46 💬
581Remicade 100 mg----[2] 56, 96 💬
582Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten----[1] 97 💬
583REMICADE 100 mg polvo para concentrado para solución para perfusión----[2] 46, 271 💬
584Remicade 100 mg powder for concentrate for solution for infusion.----[2] 96, 97 💬
585Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning----[4] 46, 96, 97, 271 💬
586Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning.----[1] 46 💬
587REMICADE*EV F 100MG+F 2ML----[1] 46 💬
588RemicadePharmaceutical Form: Powder for concentrate for solution for infusionINN or Proposed INN: INFLIXIMABCAS Number: 170277-31-3Current Sponsor code: RO6897845Other descriptive name: INFLIXIMABConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 100-Trade Name: XeljanzPharmaceutical Form: Film-coated tabletINN or Proposed INN: TOFACITINIBCAS Number: 477600-75-2Current Sponsor code: Ro 516-9503Other descriptive name: TOFACITINIBConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 5-Trade Name: XeljanzPharmaceutical Form: Film-coated tabletINN or Proposed INN: TOFACITINIBCAS Number: 477600-75-2Current Sponsor code: Ro 516-9503Other descriptive name: TOFACITINIBConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-Trade Name: StelaraPharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: USTEKINUMABCAS Number: 815610-63-0Current Sponsor code: Ro 723-3920Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 5-Trade Name: StelaraPharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: USTEKINUMABCAS Number: 815610-63-0Current Sponsor code: Ro 723-3920Other descriptive name: USTEKINUMABConcentration unit: mg/ml milligram(s)/millilitreConcentra----[1] 97 💬
589RemicadePharmaceutical Form: Powder for injection*INN or Proposed INN: INFLIXIMABCAS Number: 170277313Concentration unit: mg/kg milligram(s)/kilogramConcentration type: equalConcentration number: 5-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use----[1] 96 💬
590Remicade®----[2] 46, 271 💬
591REMICADE® (Infliximab)[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
592Remicaide (infliximab)[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 39 💬
593Remifentanil[1] Remifentanil[2] Remifentanil hydrochloride ,
Remifentanil 💬 		[1] OPRM1 💬 [5] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[4] 6, 22, 70, 96 💬
594Remimazolam[1] Remimazolam[2] Remimazolam besylate ,
Remimazolam 💬 		[16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[3] 6, 22, 97 💬
595Reminder capsules----[1] 19 💬
596Reminder Product----[1] 19 💬
597Reminyl----[1] 6 💬
598Reminyl Retard----[1] 6 💬
599Remisma----[1] 96 💬
600Remodulin----[1] 86 💬
601Remodulin (R)----[1] 88 💬
602Remodulin (treprostinil sodium)[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
603Remodulin 10mg/ml 20ml----[1] 88 💬
604Remodulin 1mg/ml 20ml----[1] 88 💬
605Remodulin 2.5mg/ml 20ml----[1] 88 💬
606Remodulin 5mg/ml 20ml----[1] 88 💬
607Remodulin® (treprostinil) 1 mg/ml solution for infusion[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
608Remodulin® (treprostinil) 10 mg/ml solution for infusion[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
609Remodulin® (treprostinil) 2.5 mg/ml solution for infusion[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
610Remodulin® (treprostinil) 5 mg/ml solution for infusion[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
611REMSIMA----[4] 46, 96, 97, 271 💬
612Remsima (CT-P13)----[1] 97 💬
613Remsima (infliximab)[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[3] 46, 96, 97 💬
614REMSIMA - 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLANCONCINO (VETRO) - 1 FLACONCINO----[4] 46, 96, 97, 271 💬
615Remsima 100 mg powder for solution for infusion----[1] 96 💬
616Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning----[4] 46, 96, 97, 271 💬
617REMSIMA 120 mg solution for injection in pre-filled syringe----[1] 96 💬
618Remsima and Inflectra----[2] 96, 97 💬
619Remsima IV----[2] 46, 271 💬
620Remsima SC----[2] 46, 271 💬
621REMSINA----[1] 96 💬
622Ren-Nu and KetoCitra----[1] 67 💬
623REN001[1] ReN001---[1] 256 💬
624Renadirsen[1] Renadirsen---[1] 113 💬
625Renal biopsy and blood sampling----[1] 49 💬
626Renal sympathetic denervation----[1] 67 💬
627Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i)----[1] 66 💬
628Renin-angiotensin sytem blockers----[1] 223 💬
629Renin-angiotensin-aldosterone system inhibitors (RASI)[1] Aldosterone[1] Aldosterone 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 222 💬
630Renishaw Drug Delivery System----[1] 6 💬
631Repagermanium----[1] 222 💬
632Repaglinide[1] Repaglinide[1] Repaglinide 💬 [2] ABCC8,
KCNJ11 💬 		[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬[4] 6, 21, 46, 299 💬
633Repaglinide and Insulin[1] Repaglinide[1] Repaglinide 💬 [2] ABCC8,
KCNJ11 💬 		[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬[1] 299 💬
634Repaglinide Tablets[1] Repaglinide[1] Repaglinide 💬 [2] ABCC8,
KCNJ11 💬 		[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬[1] 46 💬
635Repair of CDH w/Alloderm----[1] 294 💬
636Repair of CDH w/SIS Gold[1] Gold---[1] 294 💬
637Reparixin[1] Reparixin[1] Reparixin 💬 [2] CXCR1,
CXCR2 💬 		[7] Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, Human cytomegalovirus infection, Phospholipase D signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬[2] 298, 299 💬
638Repatha (evolocumab)[1] Evolocumab[1] Evolocumab 💬 [1] PCSK9 💬 [1] Cholesterol metabolism 💬[1] 79 💬
639Repatha 140 mg Solution for Injection in Pre-filled Pen----[1] 79 💬
640Repatha 140 mg soluzione per iniezione in penna preriempita.----[1] 79 💬
641Repatha 420 mg solution for injection in cartridge----[1] 79 💬
642Repatha 420 mg soluzione per iniezione in cartuccia----[1] 79 💬
643Repetitive transcranial magnetic stimulation----[1] 96 💬
644Repetitive Transcranial Magnetic Stimulation (rTMS)----[1] 149 💬
645REPLAGAL----[1] 19 💬
646Replagal (Agalsidase Alfa)[1] Agalsidase alfa[1] Agalsidase alfa 💬 [1] GLA 💬 [5] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬[1] 19 💬
647Replagal agalsidase alfa[1] Agalsidase alfa[1] Agalsidase alfa 💬 [1] GLA 💬 [5] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome biogenesis, Sphingolipid metabolism 💬[1] 19 💬
648REPLAGAL ®----[1] 19 💬
649RepomolPharmaceutical Form: Solution for infusionINN or Proposed INN: MolgramostimCAS Number: 99283-10-0Concentration unit: µg/ml microgram(s)/millilitreConcentration type: equalConcentration number: 250-----[1] 97 💬
650Repository corticotropin injection[1] Corticotropin[2] Corticotropin ,
Corticotropin, repository 💬 		[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 2, 13, 46, 84, 222 💬
651Repository Corticotropin Injection -Treatment Extension[1] Corticotropin[2] Corticotropin ,
Corticotropin, repository 💬 		[1] MC2R 💬 [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 84 💬
652Reproxalap[1] Reproxalap[1] Reproxalap 💬 --[1] 160 💬
653REQUIP----[2] 6, 309 💬
654REQUIP 21 CPR 0,25 MG----[1] 6 💬
655REQUIP 21 CPR 0,5 MG----[1] 6 💬
656REQUIP 21 CPR 1 MG----[1] 6 💬
657REQUIP 21 CPR 2 MG----[1] 6 💬
658Requip Modutab, 2mg----[1] 6 💬
659Requip Modutab, 4mg----[1] 6 💬
660Requip Modutab, 8mg----[1] 6 💬
661ReQuip PR----[1] 6 💬
662Requip prolonged release----[1] 6 💬
663Requip XL prolonged-release----[1] 6 💬
664REQUIP*21CPR 0,25MG----[1] 6 💬
665REQUIP*21CPR 0,5MG----[1] 6 💬
666REQUIP*21CPR 1MG----[1] 6 💬
667REQUIP*21CPR 5MG----[1] 6 💬
668REQUIP*28CPR 8MG R.P.----[1] 6 💬
669REQUIP-LP----[1] 6 💬
670Requip-Modutab----[1] 6 💬
671REQUIP-MODUTAB , 2mg----[1] 6 💬
672REQUIP-MODUTAB , 4mg----[1] 6 💬
673REQUIP-MODUTAB , 8mg----[1] 6 💬
674REQUIP-MODUTAB, 2mg----[1] 6 💬
675REQUIP-MODUTAB, 4mg----[1] 6 💬
676REQUIP-MODUTAB, 8mg----[1] 6 💬
677Resamirigene bilparvovec[1] Resamirigene bilparvovec---[1] 111 💬
678Rescue----[1] 2 💬
679Rescue Medication CDCA 250 mg TID----[1] 263 💬
680Rescue WLL----[1] 229 💬
681Resistant maltodextrin[1] Maltodextrin[1] Maltodextrin 💬 --[1] 6 💬
682Resistant starch----[1] 6 💬
683Resistive respiratory loads----[1] 6 💬
684Reslizumab[1] Reslizumab[1] Reslizumab 💬 [1] IL5 💬 [13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[2] 44, 98 💬
685Resmetirom[1] Resmetirom[1] Resmetirom 💬 [1] THRB 💬 [3] Hormone signaling, Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬[1] 79 💬
686RESOLOR*28CPR RIV 2MG----[1] 51 💬
687RESP301[1] RESP301---[1] 299 💬
688RESP302----[1] 299 💬
689RESP303----[1] 299 💬
690Response to anakinra associated with methotrexate[2] Anakinra,
Methotrexate		[3] Methotrexate ,
Methotrexate sodium ,
Anakinra 💬 		[4] DHFR,
DHFR2,
IL1R1,
IL1R2 💬 		[18] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[1] 46 💬
691Response to infliximab associated with methotrexate[2] Infliximab,
Methotrexate		[3] Methotrexate ,
Methotrexate sodium ,
Infliximab 💬 		[3] DHFR,
DHFR2,
TNF 💬 		[69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
692Restasis----[2] 53, 162 💬
693Restex Tabletten----[1] 6 💬
694Resunab, ajulemic acid, anabasum[1] Lenabasum[1] Lenabasum 💬 [1] CNR2 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 50, 51, 299 💬
695Resveratrol[1] Resveratrol---[10] 2, 6, 8, 18, 46, 57, 89, 97, 113, 299 💬
696Resveratrol 1 gm.[1] Resveratrol---[1] 46 💬
697Resveratrol Supplementation[1] Resveratrol---[1] 97 💬
698Retarded release phosphatidylcholine----[1] 97 💬
699Retarded Release Phosphatidylcholine (rPC)----[1] 97 💬
700Retifanlimab[1] Retifanlimab[1] Retifanlimab 💬 [1] PDCD1 💬 [3] Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[1] 34 💬
701RETIGABINE[1] Ezogabine[1] Ezogabine 💬 [5] KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬 		[7] Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, IgSF CAM signaling, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬[2] 2, 144 💬
702RETIGABINE/EZOGABINE[1] Ezogabine[1] Ezogabine 💬 [5] KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬 		[7] Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, IgSF CAM signaling, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬[1] 144 💬
703Retinal pigment epitheliums transplantation----[1] 90 💬
704Retinoic Acid Receptor gamma Agonist----[1] 231 💬
705Retrospective Case Only----[1] 172 💬
706Retrovir----[1] 135 💬
707Retroviral SF71-gp91phox transduced CD34+ cells----[1] 65 💬
708Retrovirus-mediated gene transfer----[1] 65 💬
709Rett-T----[1] 156 💬
710Reumaflex----[1] 107 💬
711Reumatocept (etanercept)[1] Etanercept[1] Etanercept 💬 [2] LTA,
TNF 💬 		[66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
712Revamilast[1] Revamilast---[1] 46 💬
713Revascularization/Conservative management----[1] 22 💬
714Revatio----[3] 85, 86, 113 💬
715REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML----[1] 294 💬
716Revatio 0.8mg/ml solution for injection----[1] 294 💬
717Revatio 10 mg/ml powder for oral suspension----[1] 86 💬
718Revatio 20 mg----[1] 85 💬
719Revatio 20 mg film coated tablets----[1] 86 💬
720Revatio 20 mg film-coated tablets----[1] 86 💬
721Revatio 20 mg Filmtabletten----[1] 86 💬
722REVATIO 20 mg, comprimidos recubiertos con película----[1] 86 💬
723Revatio inyectable----[1] 86 💬
724Revatio oral----[1] 86 💬
725Revatio POS----[1] 86 💬
726Revatio Tablets----[1] 86 💬
727Revatio®----[1] 86 💬
728REVAXIS----[1] 13 💬
729Reveglucosidase alfa[1] Reveglucosidase alfa---[1] 256 💬
730Reveglucosidase alpha----[1] 256 💬
731Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir[3] Abacavir,
Lamivudine,
Zidovudine		[4] Lamivudine ,
Zidovudine ,
Abacavir sulfate ,
Abacavir 💬 		--[1] 325 💬
732REVLIMID----[1] 28 💬
733REVLIMID*21CPS 25MG----[1] 16 💬
734REVOLADE----[2] 60, 63 💬
735REVOLADE - 25 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU) 28 COMPRESSE----[1] 60 💬
736REVOLADE - 50 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER(PA/ALU/PVC/ALU----[1] 60 💬
737Revolade 25 mg film-coated tablets----[1] 63 💬
738Revolade 50 mg film-coated tablets----[1] 63 💬
739Revolade 75 mg----[1] 60 💬
740REVOLADE*28CPR RIV 25MG----[1] 63 💬
741REVOLADE, PROMACTA----[1] 63 💬
742Revusiran[1] Revusiran---[1] 28 💬
743Rex robotic assisted balance exercises----[1] 13 💬
744Rexlemestrocel-L[1] Rexlemestrocel-L---[2] 210, 211 💬
745Reyataz----[1] 265 💬
746REYATAZ 150MG 60 CPS BL----[1] 265 💬
747RF catheter ablation----[1] 58 💬
748RFB002----[1] 166 💬
749RFB002, rhuFab V2[1] Ranibizumab[1] Ranibizumab 💬 [1] VEGFA 💬 [24] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[1] 166 💬
750RFB002A----[1] 166 💬
751RG-012----[1] 218 💬
752RG002C0106----[1] 66 💬
753RG012----[1] 218 💬
754RG1068 (Synthetic Human Secretin)----[1] 298 💬
755RG2077 (CTLA4-IgG4m)----[1] 13 💬
756RG2133 (2',3',5'-tri-O-acetyluridine)----[1] 21 💬
757RG6042, formerly ISIS 443139, IONIS-HTTRx----[1] 8 💬
758RG6496----[1] 8 💬
759RGB-03----[1] 46 💬
760RGH-706----[1] 193 💬
761RGH-706 HYDROCHLORIDE----[1] 193 💬
762RGL-193(high-dose)----[1] 6 💬
763RGL-193(low-dose)----[1] 6 💬
764RGLS4326----[1] 67 💬
765RGLS8429----[1] 67 💬
766RGX-111[1] RGX-111---[1] 19 💬
767RGX-121[1] RGX-121---[1] 19 💬
768Rh Growth Hormone----[1] 19 💬
769Rhamnose[1] Rhamnose---[1] 96 💬
770RhARSA----[1] 19 💬
771RhASA----[1] 19 💬
772RhASA - Dose Level 1----[1] 19 💬
773RhASA - Dose Level 2----[1] 19 💬
774RhASA - Dose Level 3----[1] 19 💬
775RhASA [recombinant human arylsulfatase A], formerly HGT-1110, now also known as TAK-611[2] Recombinant human arylsulfatase A,
TAK-611		---[1] 19 💬
776RhASM----[1] 19 💬
777RHB-104----[2] 13, 96 💬
778RhBSSL[1] Bucelipase alfa---[1] 299 💬
779RhC1IHN----[1] 65 💬
780RhC1INH----[1] 65 💬
781RhC1INH or pdC1INH----[1] 65 💬
782RhDNAse----[1] 299 💬
783Rheopheresis treatment----[1] 51 💬
784RhEPO[1] Erythropoietin[4] Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		[1] EPOR 💬 [7] Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[1] 13 💬
785Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)----[1] 46 💬
786RhGAA----[1] 256 💬
787RhGAA, acid alpha glucosidase----[1] 256 💬
788RhGM-CSF----[1] 229 💬
789RHGUS----[1] 19 💬
790RhHNS-10 mg----[1] 19 💬
791RhHNS-45 mg----[1] 19 💬
792RhHNS-90 mg----[1] 19 💬
793RhIDU (recombinant human-Alpha-L-Iduronidase)----[1] 19 💬
794RhIFN beta-1b----[1] 13 💬
795RhIGF (Increlex)----[1] 96 💬
796RhIGF-1----[1] 156 💬
797RhIGF-1 (CEP-151)----[1] 13 💬
798RhIGF-1/rhIGFBP-3[1] rhIGFBP-3---[1] 195 💬
799RhIGF-I/rhIGFBP-3[1] rhIGFBP-3---[1] 113 💬
800RhIGFBP-3[1] rhIGFBP-3---[2] 113, 195 💬
801RHIgM22----[1] 13 💬
802RhIL-11----[2] 63, 97 💬
803RhLAMAN[1] Velmanase alfa[1] Velmanase alfa 💬 [1] MAN2B1 💬 [2] Lysosome biogenesis, Other glycan degradation 💬[1] 19 💬
804RhNAGLU----[1] 19 💬
805RhNAGLU radiolabelled----[1] 19 💬
806RHNAGLU-IGF2[1] Tralesinidase alfa[1] Tralesinidase alfa 💬 [2] IGF2,
NAGLU 💬 		[9] Glycosaminoglycan degradation, Hepatocellular carcinoma, Hormone signaling, Lysosome biogenesis, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Ras signaling pathway 💬[1] 19 💬
807RhNGF 180 µg/ml eye drops solution----[1] 90 💬
808RhNGF 60 µg/ml eye drops solution----[1] 90 💬
809Rho(D) Immune Globulin----[1] 63 💬
810RhPRG4 (450 µg/mL)----[1] 53 💬
811RhPTH----[1] 326 💬
812RhPTH (1-34)[1] Parathyroid hormone[1] Parathyroid hormone 💬 [2] PTH1R,
PTH2R 💬 		[4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 70 💬
813RhPTH(1-84)[1] Parathyroid hormone[1] Parathyroid hormone 💬 [2] PTH1R,
PTH2R 💬 		[4] Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
814RhTPO----[2] 60, 63 💬
815RhTPO combined with Herombopag + CsA----[1] 60 💬
816RhTPO in combination with Rituximab[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 63 💬
817RhuCD40L----[1] 65 💬
818RhuDex 100 mg (127 mg RhuDex choline salt) granules[1] Choline[1] Choline 💬 --[1] 93 💬
819RhuDex 25 mg (31.75 mg RhuDex choline salt) granules[1] Choline[1] Choline 💬 --[1] 93 💬
820RhuDex 50 mg (63.5 mg RhuDex choline salt) granules[1] Choline[1] Choline 💬 --[1] 93 💬
821RhuDex choline salt[1] Choline[1] Choline 💬 --[1] 93 💬
822RHuG-CSF----[1] 18 💬
823RhuMab 2H7[1] Ocrelizumab[1] Ocrelizumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 13, 46, 49 💬
824RhuMAb Beta7----[1] 97 💬
825RhuMAb Beta7, Anti Beta 7, PRO145223----[1] 97 💬
826RhuMAb Beta7, Anti Beta7, PRO145223----[1] 97 💬
827RhuMAb IFNalpha----[1] 49 💬
828RhumAb to Il-17A (IgG1-k-class)----[4] 13, 46, 56, 96 💬
829RhumAb to Il-17A (IgG1-k-class) rhumAb to Il-17A (IgG1-k-class)----[1] 96 💬
830RhumAb to IL-17A igG1-k-class----[1] 13 💬
831RHuPH20----[2] 13, 14 💬
832Rhustoxicodendron 30----[1] 46 💬
833RhuTNFR:Fc----[2] 46, 271 💬
834RI-002----[1] 65 💬
835RIBAVIRIN[1] Ribavirin[1] Ribavirin 💬 --[2] 2, 96 💬
836Ribazen----[1] 46 💬
837Ribitol[1] Ribitol[1] Ribitol 💬 --[1] 113 💬
838Riboflavin[1] Riboflavin[1] Riboflavin 💬 --[8] 13, 38, 46, 96, 97, 162, 168, 265 💬
839Riboflavin sodium phosphate[2] Flavin mononucleotide,
Riboflavin		[2] Riboflavin ,
Riboflavin sodium phosphate 💬 		--[1] 96 💬
840Riboflavin Sodium Phosphate Injection[2] Flavin mononucleotide,
Riboflavin		[2] Riboflavin ,
Riboflavin sodium phosphate 💬 		--[1] 96 💬
841Riboflavin supplementation[1] Riboflavin[1] Riboflavin 💬 --[1] 96 💬
842Ribose[1] Ribose---[1] 131 💬
843RIC----[1] 22 💬
844RIC alloBMT w PTCy in refractory SSc----[1] 51 💬
845Rice[1] Rice[1] Brown rice 💬 --[1] 53 💬
846Rice/turkey free diet (R/TFD) group[2] Rice,
Turkey		[1] Brown rice 💬 --[1] 53 💬
847Riciguat Group----[1] 86 💬
848RIFABUTIN[1] Rifabutin[1] Rifabutin 💬 --[2] 96, 299 💬
849Rifabutin, Clarithromycin, and Clofazimine[3] Clarithromycin,
Clofazimine,
Rifabutin		[3] Clarithromycin ,
Clofazimine ,
Rifabutin 💬 		--[1] 96 💬
850Rifampicin[1] Rifampin[2] Rifampin ,
Rifampicin sodium 💬 		--[6] 6, 13, 17, 46, 93, 299 💬
851Rifampin[1] Rifampin[2] Rifampin ,
Rifampicin sodium 💬 		--[5] 6, 13, 84, 86, 299 💬
852Rifampin 300mg BID + istradefylline 40mg Day 8 only[2] Istradefylline,
Rifampin		[3] Rifampin ,
Istradefylline ,
Rifampicin sodium 💬 		[1] ADORA2A 💬 [8] Alcoholism, Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6 💬
853Rifampin and azithromycin.[2] Azithromycin,
Rifampin		[5] Rifampin ,
Azithromycin hydrate ,
Azithromycin ,
Azithromycin ,
Rifampicin sodium 💬 		--[1] 84 💬
854Rifaximin[1] Rifaximin[1] Rifaximin 💬 --[8] 6, 65, 93, 96, 97, 99, 296, 299 💬
855Rifaximin 550 MG[1] Rifaximin[1] Rifaximin 💬 --[1] 6 💬
856Rifaximin 550 MG Oral Tablet [XIFAXAN][1] Rifaximin[1] Rifaximin 💬 --[1] 299 💬
857Rifaximin Delayed Release (DR)[1] Rifaximin[1] Rifaximin 💬 --[1] 96 💬
858Rifaximin delayed release 400 mg film coated tablet[1] Rifaximin[1] Rifaximin 💬 --[1] 96 💬
859Rifaximin delayed release tablets[1] Rifaximin[1] Rifaximin 💬 --[1] 96 💬
860Rifaximin EIR[1] Rifaximin[1] Rifaximin 💬 --[1] 96 💬
861Rifaximin oral tablet[1] Rifaximin[1] Rifaximin 💬 --[1] 99 💬
862Rifaximin+omeprazole+miralax[2] Omeprazole,
Rifaximin		[4] Omeprazole ,
Omeprazole sodium ,
Rifaximin ,
Omeprazole magnesium 💬 		[2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[1] 96 💬
863Rifaximin-EIR[1] Rifaximin[1] Rifaximin 💬 --[1] 96 💬
864RIFAXIMINA[1] Rifaximin[1] Rifaximin 💬 --[1] 96 💬
865Rigerimod----[1] 49 💬
866Right Heart Catheterization----[1] 18 💬
867Rigosertib[1] Rigosertib[2] Rigosertib ,
Rigosertib sodium 💬 		[1] PLK1 💬 [4] Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 36 💬
868Rigosertib Oral Capsules / Rigosertib Intravenous[1] Rigosertib[2] Rigosertib ,
Rigosertib sodium 💬 		[1] PLK1 💬 [4] Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 36 💬
869Rigosertib Sodium[1] Rigosertib[2] Rigosertib ,
Rigosertib sodium 💬 		[1] PLK1 💬 [4] Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 36 💬
870RIL-1RA----[1] 107 💬
871Riliprubart[1] Riliprubart[1] Riliprubart 💬 [1] C1S 💬 [5] Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 14 💬
872Riliprubart Prefilled Pen (PFP)[1] Riliprubart[1] Riliprubart 💬 [1] C1S 💬 [5] Complement and coagulation cascades, Coronavirus disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 14 💬
873Rilmenidine[1] Rilmenidine[1] Rilmenidine 💬 [3] ADRA2A,
ADRA2B,
ADRA2C 💬 		[4] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 8 💬
874Rilonacept[1] Rilonacept[1] Rilonacept 💬 [2] IL1A,
IL1B 💬 		[44] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬[5] 51, 84, 106, 107, 266 💬
875Rilonacept (IL-1 Trap)[1] Rilonacept[1] Rilonacept 💬 [2] IL1A,
IL1B 💬 		[44] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬[1] 107 💬
876Rilonacept 160 mg[1] Rilonacept[1] Rilonacept 💬 [2] IL1A,
IL1B 💬 		[44] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬[1] 106 💬
877RILUTEK----[3] 2, 13, 203 💬
878Rilutek 50 mg film-coated tablets----[1] 2 💬
879RILUTEK 50 mg, film-coated tablets----[1] 2 💬
880RILUZOLE[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[9] 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
881Riluzole (100 mg)[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2 💬
882Riluzole 100mg/day[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2 💬
883Riluzole 50 MG[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2 💬
884Riluzole 50 MG (Part B)[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2 💬
885Riluzole Oral Soluble Film[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2 💬
886Riluzole Oral Soluble film (ROSF) 50 mg[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2 💬
887Riluzole PMCS[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 18 💬
888Riluzole tablet[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[1] 2 💬
889RILUZOLO----[3] 2, 18, 114 💬
890RILUZOLO TEVA - 50 MG COMPRESSE RIVESTITE CON FILM 90 COMPRESSE IN BLISTER AL/PVC----[1] 114 💬
891Rilzabrutinib[1] Rilzabrutinib[1] Rilzabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[6] 35, 61, 63, 222, 223, 300 💬
892Rilzabrutinib Oral Tablet[1] Rilzabrutinib[1] Rilzabrutinib 💬 [1] BTK 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬[1] 35 💬
893Rimacalib[1] Rimacalib---[1] 46 💬
894Rimactan----[1] 299 💬
895Rimegepant[1] Rimegepant[2] Rimegepant ,
Rimegepant sulfate 💬 		[1] CALCRL 💬 [2] Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬[1] 226 💬
896Rimeporide[1] Rimeporide---[1] 113 💬
897Rimiducid[1] Rimiducid[1] Rimiducid 💬 [1] CASP9 💬 [34] Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Colorectal cancer, Endometrial cancer, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Huntington disease, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Measles, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parkinson disease, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Prostate cancer, Small cell lung cancer, Thyroid hormone signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Viral myocarditis, p53 signaling pathway 💬[7] 19, 49, 60, 65, 284, 285, 326 💬
898Rimonabant[1] Rimonabant[1] Rimonabant 💬 [1] CNR1 💬 [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬[1] 193 💬
899RIMSO 50----[1] 226 💬
900Ringer lactate----[1] 51 💬
901Rinvoq----[1] 271 💬
902Riocigu----[1] 51 💬
903RIOCIGUAT[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[6] 51, 84, 86, 88, 225, 299 💬
904Riociguat (Adempas)[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 88 💬
905Riociguat (Adempas, BAY63-2521)[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[4] 51, 86, 88, 299 💬
906Riociguat (BAY63-2521)[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
907Riociguat 0.5 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
908Riociguat 1.0 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
909Riociguat 1.5 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
910Riociguat 2.0 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
911Riociguat 2.5 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
912Riociguat coated tablet 0.5 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 51 💬
913Riociguat coated tablet 1.0 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 51 💬
914Riociguat coated tablet 1.5 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 51 💬
915Riociguat coated tablet 2.0 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 51 💬
916Riociguat coated tablet 2.5 m[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 51 💬
917Riociguat coated tablet 2.5 mg[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 51 💬
918Riociguat film coated tablets[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
919Riociguat granules 0.3% for oral application[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
920Riociguat Oral Product[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
921Riociguat Oral Tablet[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[3] 51, 86, 88 💬
922Riociguat Pill[1] Riociguat[1] Riociguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
923Ripertamab[1] Ripertamab---[4] 11, 14, 63, 222 💬
924RIPK1 inhibitor----[1] 13 💬
925RIQUENT----[1] 49 💬
926Risankizumab[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[4] 37, 96, 97, 271 💬
927Risankizumab (RISA)[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
928Risankizumab 10 mg/ml[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
929Risankizumab 180 mg SC[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
930Risankizumab 600 mg IV[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
931Risankizumab 90 mg/ml[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
932Risankizumab IV[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
933Risankizumab On-Body Injector (OBI)[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
934Risankizumab SC[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
935Risankizumab-800CW 15 mg[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
936Risankizumab-800CW 15 mg/25 mg[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
937Risankizumab-800CW 25 mg[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
938Risankizumab-800CW 4.5 mg[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
939Risankizumab-800CW optimal dose[1] Risankizumab[1] Risankizumab 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
940RisankizumabProduct Code: ABBV-006Pharmaceutical Form: Solution for infusionINN or Proposed INN: RISANKIZUMABCurrent Sponsor code: ABBV-066Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 90-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous useProduct Name: RisankizumabProduct Code: ABBV-066Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: RISANKIZUMABCurrent Sponsor code: ABBV-066Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 90-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useProduct Name: RisankizumabProduct Code: ABBV-006Pharmaceutical Form: Solution for infusionINN or Proposed INN: RISANKIZUMABCurrent Sponsor code: ABBV-066Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 60-----[1] 97 💬
941Risdiplam[1] Risdiplam[1] Risdiplam 💬 --[1] 3 💬
942Risedronate[1] Risedronic acid[3] Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[2] 96, 113 💬
943Risedronate Oral Tablet----[1] 274 💬
944Risedronate sodium[1] Risedronic acid[3] Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[5] 46, 50, 107, 113, 274 💬
945Risedronate sodium (Actonel)[1] Risedronic acid[3] Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[1] 274 💬
946Risedronate sodium 2.5mg[1] Risedronic acid[3] Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[1] 274 💬
947Risedronate sodium 5mg[1] Risedronic acid[3] Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[1] 274 💬
948Risedronato sódico 2.5mg----[1] 274 💬
949Risedronato sódico 5mg----[1] 274 💬
950Risedronic acid[1] Risedronic acid[3] Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[3] 93, 95, 274 💬
951Risperdal----[1] 203 💬
952Risperidone[1] Risperidone[1] Risperidone 💬 [2] DRD2,
HTR2A 💬 		[13] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬[6] 8, 74, 156, 179, 187, 206 💬
953Risperidone 1Mg Tab[1] Risperidone[1] Risperidone 💬 [2] DRD2,
HTR2A 💬 		[13] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬[1] 8 💬
954Risperidone or paliperidone[2] Paliperidone,
Risperidone		[3] Risperidone ,
Paliperidone ,
Paliperidone palmitate 💬 		[2] DRD2,
HTR2A 💬 		[13] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬[1] 74 💬
955RIST4721----[1] 266 💬
956Ritalin----[2] 6, 13 💬
957Ritalin LA 20mg capsules----[1] 13 💬
958Ritalin LA 30mg capsules----[1] 13 💬
959Ritalin LA 40mg capsules----[1] 13 💬
960Ritivixibat[1] Ritivixibat---[1] 94 💬
961Ritlecitinib[1] Ritlecitinib[1] Ritlecitinib tosylate 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[3] 46, 96, 97 💬
962Ritlecitinib 10 mg[1] Ritlecitinib[1] Ritlecitinib tosylate 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 97 💬
963Ritlecitinib 5 mg[1] Ritlecitinib[1] Ritlecitinib tosylate 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 97 💬
964Ritlecitinib 50 mg[1] Ritlecitinib[1] Ritlecitinib tosylate 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[2] 96, 97 💬
965Ritlecitinib 50mg[1] Ritlecitinib[1] Ritlecitinib tosylate 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 96 💬
966Ritlecitinib/JAK 3[1] Ritlecitinib[1] Ritlecitinib tosylate 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 46 💬
967Ritonavir[1] Ritonavir[1] Ritonavir 💬 --[3] 2, 86, 265 💬
968Ritonavir (Norvir)[1] Ritonavir[1] Ritonavir 💬 --[1] 265 💬
969Ritumax®----[1] 46 💬
970Rituxan----[5] 46, 60, 63, 256, 288 💬
971Rituxan (INN: Rituximab), brand name in the United States[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
972Rituxan (INN: Rituximab), brand name in the US[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
973Rituxan (rituximab)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 49 💬
974Rituxan (US, Canada, Japan), MabThera (rest of the world)----[1] 46 💬
975Rituxan (US, Canada, Japan), MabThera (rest of world)----[1] 53 💬
976Rituxan treatment----[1] 113 💬
977Rituxan, Cyclophosphamide, Vincristine, Prednisone[3] Cyclophosphamide,
Prednisone,
Vincristine		[5] Cyclophosphamide ,
Prednisone ,
Vincristine sulfate ,
Cyclophosphamide ,
Vincristine 💬 		[10] NR3C1,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[13] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 63 💬
978Rituxan®----[1] 46 💬
979Rituxan® (rituximab)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
980RITUXIMAB[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[54] 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
981Rituximab (active comparator)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
982Rituximab (anti-CD20)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 53 💬
983Rituximab (Arm A)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 43, 44 💬
984Rituximab (Arm B)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 43, 44, 63 💬
985Rituximab (EU)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
986Rituximab (genetical recombination)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 14, 222, 223 💬
987Rituximab (MABTHERA and BIOSIMILARS)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 35, 162 💬
988Rituximab (Mabthera ®) Belimumab (Benlysta ®)[2] Belimumab,
Rituximab		[2] Rituximab ,
Belimumab 💬 		[2] MS4A1,
TNFSF13B 💬 		[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 63 💬
989Rituximab (Mabthera)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 14, 63 💬
990Rituximab (MABTHERA® or RITUXAN®).[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 35, 61, 63 💬
991Rituximab (Mabthera®)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 61 💬
992Rituximab (R)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 13, 43, 44 💬
993Rituximab (Rituxan)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 11 💬
994Rituximab (RTX) and Azathioprine (AZA)[2] Azathioprine,
Rituximab		[3] Azathioprine ,
Rituximab ,
Azathioprine sodium 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 65 💬
995Rituximab (US)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
996Rituximab - MabThera[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
997Rituximab 1g IV[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 162 💬
998Rituximab 1g/6months[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
999Rituximab 200mg/6months[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
1000Rituximab [MabThera/Rituxan][1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 46, 63 💬
1001Rituximab [MabThera][1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
1002Rituximab and Cyclophosphamide IV[2] Cyclophosphamide,
Rituximab		[3] Cyclophosphamide ,
Rituximab ,
Cyclophosphamide 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 35 💬
1003Rituximab and dexamethasone[2] Dexamethasone,
Rituximab		[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Rituximab ,
Dexamethasone phosphate 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63 💬
1004Rituximab and Hyaluronidase Human[2] Hyaluronidase,
Rituximab		[4] Rituximab ,
Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 331 💬
1005Rituximab Biosimilar[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 222 💬
1006Rituximab Biosimilar ABP 798[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 222 💬
1007Rituximab combined with corticosteroids[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 222 💬
1008Rituximab combined with Daratumumab(Anti-CD38 Monoclonal Antibody)[2] Daratumumab,
Rituximab		[2] Rituximab ,
Daratumumab 💬 		[2] CD38,
MS4A1 💬 		[6] Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬[1] 63 💬
1009Rituximab combined with Omalizumab[2] Omalizumab,
Rituximab		[2] Rituximab ,
Omalizumab 💬 		[2] FCER1A,
MS4A1 💬 		[5] Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 162 💬
1010Rituximab combined with tacrolimus induction + rituximab maintenance[2] Rituximab,
Tacrolimus		[3] Tacrolimus ,
Rituximab ,
Tacrolimus 💬 		[6] MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222 💬
1011Rituximab combined with tacrolimus induction + tacrolimus maintenance[2] Rituximab,
Tacrolimus		[3] Tacrolimus ,
Rituximab ,
Tacrolimus 💬 		[6] MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 222 💬
1012Rituximab Infusion[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 13, 222, 223 💬
1013Rituximab Injection[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[3] 11, 35, 222 💬
1014Rituximab IT[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1015Rituximab IV[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1016Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1017Rituximab MabThera[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
1018Rituximab plus methylprednisolone[2] Methylprednisolone,
Rituximab		[3] Methylprednisolone ,
Methylprednisolone acetate ,
Rituximab 💬 		[2] MS4A1,
NR3C1 💬 		[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63 💬
1019Rituximab(RTX)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 13 💬
1020Rituximab, Cyclophosphamide, and Corticosteroids[2] Cyclophosphamide,
Rituximab		[3] Cyclophosphamide ,
Rituximab ,
Cyclophosphamide 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 222 💬
1021Rituximab, Mabthera[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 53 💬
1022Rituximab, MTX, folic acid[2] Folic acid,
Rituximab		[3] Folic acid ,
Rituximab ,
Folate sodium 💬 		[1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
1023Rituximab, observational study amon patients with active RA[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
1024Rituximab-EU+ Rituximab-Pfizer x 2 Courses[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
1025Rituximab-Pfizer[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
1026Rituximab-Pfizer (PF-05280586) x 3 courses[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
1027Rituximab-US + Rituximab-Pfizer x 2 Courses[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
1028Rituximab/ Mabthera[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 271 💬
1029RIV-TDS 13.3 mg/24 h----[1] 6 💬
1030Rivaroxaban[1] Rivaroxaban[1] Rivaroxaban 💬 [1] F10 💬 [1] Complement and coagulation cascades 💬[10] 46, 48, 49, 56, 58, 75, 91, 210, 222, 271 💬
1031Rivaroxaban 10 MG[1] Rivaroxaban[1] Rivaroxaban 💬 [1] F10 💬 [1] Complement and coagulation cascades 💬[1] 222 💬
1032Rivaroxaban 20 mg[1] Rivaroxaban[1] Rivaroxaban 💬 [1] F10 💬 [1] Complement and coagulation cascades 💬[1] 91 💬
1033Rivaroxaban plus immunosupression[1] Rivaroxaban[1] Rivaroxaban 💬 [1] F10 💬 [1] Complement and coagulation cascades 💬[1] 56 💬
1034Rivastigmin----[1] 13 💬
1035Rivastigmin Luye Transdermal Patches - 4.6mg/24h----[1] 6 💬
1036RIVASTIGMINE[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[3] 5, 6, 13 💬
1037Rivastigmine capsule[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
1038Rivastigmine CF[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
1039Rivastigmine Luye Transdermal Patch- 9.5mg/24h[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
1040Rivastigmine Patch 9.5 cm2[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
1041Rivastigmine transdermal patch[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[2] 6, 13 💬
1042Rivastigmine Transdermal System[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
1043Rivastigmine transdermal system 13.3 mg/24 h[1] Rivastigmine[2] Rivastigmine tartrate ,
Rivastigmine 💬 		[1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[1] 6 💬
1044Rivenprost[1] Rivenprost---[1] 97 💬
1045Rivenprost (drug)[1] Rivenprost---[1] 97 💬
1046Rivogenlecleucel[1] Rivogenlecleucel[1] Rivogenlecleucel 💬 --[6] 19, 60, 65, 284, 285, 326 💬
1047Rivogenleucleucel----[3] 60, 285, 326 💬
1048Rixathon----[3] 13, 46, 49 💬
1049RIXATHON 500 mg----[1] 85 💬
1050RIXATHON 500mg----[1] 43 💬
1051RIXATHON® 500 mg----[1] 222 💬
1052Rizankisumab----[1] 96 💬
1053Rizankizumab----[1] 96 💬
1054RJK002 Intrathecal injection----[1] 2 💬
1055RJMty19 (CD19-CAR-DNT cells)----[1] 49 💬
1056RLY-2608[1] RLY-2608---[3] 138, 278, 281 💬
1057RM-131----[1] 6 💬
1058RM-493----[2] 193, 202 💬
1059RN316----[1] 79 💬
1060RN316)----[1] 79 💬
1061RN624, RI624----[1] 226 💬
1062RNA antisense oligonucleotide for intravitreal injection----[2] 90, 303 💬
1063RNDP-001----[1] 6 💬
1064RNF----[1] 13 💬
1065RNL-Vascostem®----[1] 47 💬
1066RNS60----[2] 2, 13 💬
1067RNS60 125 ml----[1] 13 💬
1068RNS60 250 ml----[1] 13 💬
1069RO----[1] 6 💬
1070Ro 001-9265----[1] 41 💬
1071Ro 001-9265/F02----[1] 41 💬
1072RO 001-9265/F02-01----[1] 46 💬
1073Ro 001-9265/F03----[1] 41 💬
1074Ro 001-9265/F04----[1] 41 💬
1075Ro 002-9893/F02----[1] 46 💬
1076Ro 106-1443----[1] 49 💬
1077Ro 45-2294----[1] 46 💬
1078Ro 47-0203----[4] 51, 85, 86, 88 💬
1079Ro 48-77533----[1] 46 💬
1080Ro 487-533/F01----[1] 271 💬
1081Ro 487-5733/F01----[1] 271 💬
1082RO 487-7533----[1] 46 💬
1083Ro 487-7533/F01----[3] 46, 107, 271 💬
1084Ro 487-7533/F10----[2] 46, 107 💬
1085Ro 487-7533/F10-02----[1] 46 💬
1086Ro 487-7533/F10-04----[4] 41, 46, 51, 107 💬
1087Ro 491-7523/F18----[1] 206 💬
1088Ro 491-7523/F19----[1] 206 💬
1089RO 496-4913----[2] 46, 49 💬
1090Ro 496-4913/F03----[2] 13, 46 💬
1091Ro 496-4913/F07----[1] 13 💬
1092RO 5072759----[1] 49 💬
1093Ro 533-3787/F01- 06----[1] 13 💬
1094RO 533-3787/F01-06----[1] 11 💬
1095Ro 549-0261/F04----[1] 97 💬
1096Ro 549-0261/F04-02----[1] 96 💬
1097Ro 549-0261/F08-02----[1] 96 💬
1098RO 551-6922----[1] 46 💬
1099Ro 723-4292/F02----[1] 8 💬
1100Ro Actemra----[1] 46 💬
1101Ro-47-0203----[1] 86 💬
1102Ro-47-0203/029----[1] 86 💬
1103RO-496-4913----[1] 46 💬
1104Ro-Actemra----[2] 46, 107 💬
1105RO001-9265/F04----[1] 46 💬
1106RO0029893----[1] 46 💬
1107RO0220912----[1] 85 💬
1108RO0280296----[1] 85 💬
1109RO045-2294----[1] 46 💬
1110RO0452294/V01----[2] 43, 44 💬
1111RO0452294/V02----[3] 35, 43, 44 💬
1112RO0485337----[1] 222 💬
1113RO04877533----[1] 46 💬
1114RO04877533/F05/F04----[1] 46 💬
1115RO0506997----[2] 13, 46 💬
1116Ro106-1443----[1] 43 💬
1117RO1061443/F02----[1] 35 💬
1118RO3300074----[1] 231 💬
1119RO4402257----[1] 46 💬
1120Ro45-2294----[1] 271 💬
1121RO452294/V02----[1] 46 💬
1122Ro487-7533----[1] 46 💬
1123RO487-7533/F01-F05----[1] 46 💬
1124RO487-7533/F10-04----[2] 46, 51 💬
1125RO4877533----[2] 46, 107 💬
1126RO4877533 (TCZ)----[2] 46, 107 💬
1127RO4877533/F01----[1] 46 💬
1128RO4877533/F04-F05----[1] 46 💬
1129RO4917523----[1] 206 💬
1130RO4917523 0.5 mg----[1] 206 💬
1131RO4917523 1.5 mg----[1] 206 💬
1132RO496-4913----[1] 46 💬
1133RO4964913----[1] 13 💬
1134RO4964913 F07----[1] 13 💬
1135RO4964913/F03----[1] 13 💬
1136RO4964913/F07----[1] 13 💬
1137RO4964913/F07-01----[1] 13 💬
1138RO5072759----[1] 222 💬
1139RO5333787----[2] 11, 13 💬
1140RO545-9072/F03----[1] 53 💬
1141RO5459072----[1] 53 💬
1142Ro549-0261/F04-02----[1] 96 💬
1143RO5490255/F01-02----[1] 85 💬
1144RO5490261 / F02----[1] 97 💬
1145RO5490261/F02----[1] 97 💬
1146RO5534262 EMICIZUMAB[1] Emicizumab[1] Emicizumab 💬 [2] F10,
F9 💬 		[1] Complement and coagulation cascades 💬[1] 288 💬
1147RO6885247----[1] 3 💬
1148RO6885247/F02----[1] 3 💬
1149RO6885247/F03----[1] 3 💬
1150RO7010939----[2] 13, 46 💬
1151RO7010939/F13----[1] 49 💬
1152RO7034067----[1] 3 💬
1153RO7034067 / F12----[1] 3 💬
1154RO7034067 / F13----[1] 3 💬
1155RO7034067/F06 + solvente (RO----[1] 3 💬
1156RO7034067/F06 with solvent (RO7034067/F08)----[1] 3 💬
1157RO7034067/F07 + solvente (RO----[1] 3 💬
1158RO7034067/F07 with solvent (RO7034067/F09)----[1] 3 💬
1159RO7034067/F12----[1] 3 💬
1160RO7034067/F13----[1] 3 💬
1161RO7046015----[1] 6 💬
1162RO7046015/PRASINEZUMAB[1] Prasinezumab[1] Prasinezumab 💬 [1] SNCA 💬 [3] Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬[1] 6 💬
1163RO7049665----[2] 95, 97 💬
1164RO7049665/IgG-IL2/ IgG-IL2ND2----[1] 95 💬
1165RO7090919----[1] 3 💬
1166RO7112689----[1] 62 💬
1167RO7112689/F01----[1] 62 💬
1168RO7112689/F03-01----[2] 62, 109 💬
1169RO7112689/F03-03----[1] 62 💬
1170RO7112689/F03-10----[2] 62, 109 💬
1171RO7121932 IV----[1] 13 💬
1172RO7121932 SC----[1] 13 💬
1173RO7123520----[1] 46 💬
1174RO7123520/F03-01----[1] 46 💬
1175RO720-4239/F01-01----[1] 113 💬
1176RO72042369/F03-01----[1] 3 💬
1177RO7204239----[2] 3, 113 💬
1178RO7204239/F01-01----[1] 3 💬
1179RO7204239/F03-01----[1] 3 💬
1180RO7234292----[1] 8 💬
1181RO7234292 (RG6042)----[1] 8 💬
1182RO7239361----[1] 113 💬
1183RO7239361 (BMS-986089)----[1] 113 💬
1184RO7239361 Injections, 15 mg/Syringe (21.4 mg/mL)----[1] 113 💬
1185RO7239361 Injections, 35 mg/Syringe (50 mg/mL)----[1] 113 💬
1186RO7239361 Injections, 50 mg/Syringe (71.4 mg/mL)----[1] 113 💬
1187RO7239361 Injections, 7.5 mg/Syringe (10.7 mg/mL)----[1] 113 💬
1188RO7246311----[1] 97 💬
1189RO7248824----[1] 201 💬
1190RO7248824/F02-01----[1] 201 💬
1191RO7248824/F03-01 (Diluent for RO7248824/F02-01----[1] 201 💬
1192RO7268489----[1] 13 💬
1193RO7303509----[1] 51 💬
1194RO7486967----[1] 6 💬
1195RO7490677----[1] 85 💬
1196RO7490677 160 mg/8 ml----[1] 85 💬
1197RO7490677 160 mg/8mL----[1] 85 💬
1198RO7490677 160mg/8mL----[1] 85 💬
1199RO7490677 320 mg/16 ml (2nd generation)----[1] 85 💬
1200RO7490677 320mg/16mL (1st generation)----[1] 85 💬
1201RO7490677 320mg/16mL (2nd generation)----[1] 85 💬
1202RO7490677/ F01-02----[1] 85 💬
1203RO7490677/F01-01----[1] 85 💬
1204RO7490677/F01-02----[1] 85 💬
1205RO7490677/F01-03----[1] 85 💬
1206RO7494222 (SRP-9001)----[1] 113 💬
1207RO7507062----[1] 49 💬
1208RO7837195----[1] 97 💬
1209RoActemra----[7] 41, 44, 46, 51, 86, 107, 271 💬
1210RoActemra (R)----[1] 46 💬
1211ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE----[2] 46, 51 💬
1212ROACTEMRA - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 4ML 1 FLACONCINO----[1] 46 💬
1213RoActemra 162 mg----[2] 46, 51 💬
1214RoActemra 162 mg solution for injection in pre-filled syringe----[1] 41 💬
1215RoActemra 162 mg solution injectable en seringue préremplie----[2] 46, 56 💬
1216RoActemra 162 mg soluzione iniettabile in siringa preriempita----[1] 50 💬
1217RoActemra 20 mg/ml concentrado para solución para perfusión----[1] 46 💬
1218RoActemra 20 mg/ml Concentrate for solution for infusion----[1] 46 💬
1219RoActemra 20 mg/mL concentrate for solution for infusion.----[1] 46 💬
1220ROACTEMRA 20 mg/ml, concentrado para solución para perfusión----[3] 46, 107, 271 💬
1221RoActemra 20mg/ml----[1] 40 💬
1222RoActemra(R)----[1] 46 💬
1223RoActemra/Actemra (tocilizumab)[1] Tocilizumab[1] Tocilizumab 💬 [1] IL6R 💬 [11] Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 107 💬
1224RoActemra®----[2] 46, 271 💬
1225RoActemra® 20mg/ml Konzentrat----[1] 266 💬
1226RoActemra®EV Product Code: PRD82321----[1] 46 💬
1227RoActemre----[1] 41 💬
1228RoActerma----[1] 46 💬
1229RoActmera----[1] 46 💬
1230RoadMAB----[1] 96 💬
1231RoadMAB precision dashboard----[1] 96 💬
1232Rob 803----[1] 46 💬
1233Rob 803 (9-Chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-b] quinoxali----[1] 46 💬
1234Rob 803 (capsules 12.5 mg)----[1] 46 💬
1235Rob 803 (capsules 15 mg)----[1] 46 💬
1236Rob 803 (capsules 25 mg)----[1] 46 💬
1237Rob 803 (capsules 6.25 mg)----[1] 46 💬
1238Rob 803 12.5mg capsule----[1] 46 💬
1239Rob 803 15mg capsule----[1] 46 💬
1240Rob 803 25mg capsule----[1] 46 💬
1241Rob 803 6.25mg capsule----[1] 46 💬
1242Rob 803 6.5mg capsule----[1] 46 💬
1243ROC-101----[1] 86 💬
1244Rocaltrol----[1] 63 💬
1245Rocuronium[1] Rocuronium[1] Rocuronium bromide 💬 [16] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB2,
CHRNB3,
CHRNB4 💬 		[16] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[2] 70, 296 💬
1246Rocuronium Bromide[1] Rocuronium[1] Rocuronium bromide 💬 [16] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB2,
CHRNB3,
CHRNB4 💬 		[16] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 70 💬
1247Rodatristat[1] Rodatristat[1] Rodatristat 💬 [1] TPH1 💬 [3] Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬[1] 86 💬
1248Rodatristat ethyl[2] Rodatristat,
Rodatristat ethyl		[2] Rodatristat ,
Rodatristat ethyl 💬 		[1] TPH1 💬 [3] Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬[1] 86 💬
1249Rodatristat ethyl 300 mg tablet BID[2] Rodatristat,
Rodatristat ethyl		[2] Rodatristat ,
Rodatristat ethyl 💬 		[1] TPH1 💬 [3] Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬[1] 86 💬
1250Rodatristat ethyl 600 mg BID[2] Rodatristat,
Rodatristat ethyl		[2] Rodatristat ,
Rodatristat ethyl 💬 		[1] TPH1 💬 [3] Folate biosynthesis, Serotonergic synapse, Tryptophan metabolism 💬[1] 86 💬
1251Rofecoxib[1] Rofecoxib[1] Rofecoxib 💬 [1] PTGS2 💬 [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46 💬
1252Roferon-A 3miu----[1] 56 💬
1253Roferon-A, 3miu----[1] 56 💬
1254Roferon-A, 4.5miu----[1] 56 💬
1255Roferon-A, 6miu----[1] 56 💬
1256Roflumilast[1] Roflumilast[1] Roflumilast 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[5] 46, 84, 97, 206, 299 💬
1257Roflumilast 500 Mcg Oral Tablet[1] Roflumilast[1] Roflumilast 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 46 💬
1258Roflumilast 500 MCG Oral Tablet [DALIRESP][1] Roflumilast[1] Roflumilast 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 97 💬
1259Roflumilast Oral Tablet[1] Roflumilast[1] Roflumilast 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 299 💬
1260Rokan (r) Novo 120 mg----[1] 18 💬
1261Rolipram[1] Rolipram[1] Rolipram 💬 [4] PDE4A,
PDE4B,
PDE4C,
PDE4D 💬 		[4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[2] 8, 13 💬
1262Romiplostim[1] Romiplostim[1] Romiplostim 💬 [1] MPL 💬 [3] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬[4] 60, 63, 64, 65 💬
1263Romiplostim and danazol[2] Danazol,
Romiplostim		[2] Danazol ,
Romiplostim 💬 		[4] AR,
ESR1,
MPL,
PGR 💬 		[14] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, JAK-STAT signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 63 💬
1264Romiplostim N01[1] Romiplostim[1] Romiplostim 💬 [1] MPL 💬 [3] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬[2] 60, 63 💬
1265Romiplostim N01 combined with dexamethasone[2] Dexamethasone,
Romiplostim		[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Romiplostim 💬 		[2] MPL,
NR3C1 💬 		[4] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 63 💬
1266Romiplostim plus dexamethasone[2] Dexamethasone,
Romiplostim		[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Romiplostim 💬 		[2] MPL,
NR3C1 💬 		[4] Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 63 💬
1267Romiplostin----[1] 63 💬
1268Romosozumab[1] Romosozumab[1] Romosozumab 💬 [1] SOST 💬 [2] Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬[2] 46, 274 💬
1269Rontalizumab[1] Rontalizumab[1] Rontalizumab 💬 [13] IFNA1,
IFNA10,
IFNA13,
IFNA14,
IFNA16,
IFNA17,
IFNA2,
IFNA21,
IFNA4,
IFNA5,
IFNA6,
IFNA7,
IFNA8 💬 		[25] Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬[1] 49 💬
1270ROP----[1] 6 💬
1271ROP+L-Dopa----[1] 6 💬
1272ROPINIROLE[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 6, 74, 309 💬
1273Ropinirole (as hydrochloride)[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1274Ropinirole controlled-release (REQUIP CR) for RLS[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1275Ropinirole CR 2mg tablet[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1276Ropinirole CR 8mg tablet[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1277Ropinirole Hydrochloride[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 309 💬
1278Ropinirole hydrochloride prolonged release[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1279Ropinirole immediate release[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1280Ropinirole Implant[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1281Ropinirole IR[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1282Ropinirole IR Tablets[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1283Ropinirole monotherapy[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1284Ropinirole oral product[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1285Ropinirole PR[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1286Ropinirole PR, 2mg[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1287Ropinirole PR/XR[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1288Ropinirole PR/XR Tablets[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1289Ropinirole Prolonged release[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1290Ropinirole prolonged release/extended release(PR/XR)[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1291Ropinirole XL[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1292Ropinirole XL (formerly CR)[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1293Ropinirole/L-dopa[1] Ropinirole[2] Ropinirole hydrochloride ,
Ropinirole 💬 		[3] DRD2,
DRD3,
DRD4 💬 		[10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1294Ropivacaine[1] Ropivacaine[2] Ropivacaine hydrochloride ,
Ropivacaine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[7] 22, 36, 46, 63, 70, 71, 97 💬
1295Ropivacaine Hydrochloride Injection[1] Ropivacaine[2] Ropivacaine hydrochloride ,
Ropivacaine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 70 💬
1296Ropivacaine plus normal saline[1] Ropivacaine[2] Ropivacaine hydrochloride ,
Ropivacaine 💬 		[6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 70 💬
1297Ropivacaine, Epinephrine, Clonidine, and Ketorolac Injection Cocktail[4] Clonidine,
Epinephrine,
Ketorolac,
Ropivacaine		[9] Epinephrine ,
Clonidine ,
Clonidine hydrochloride ,
Ketorolac tromethamine ,
Epinephrine hydrochloride ,
Epinephrine bitartrate ,
Ropivacaine hydrochloride ,
Ketorolac ,
Ropivacaine 💬 		[17] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
PTGS1,
PTGS2,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[42] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Efferocytosis, Gap junction, Hormone signaling, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, IgSF CAM signaling, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thermogenesis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 70 💬
1298Roscovitine----[1] 299 💬
1299Rosemary[1] Rosemary---[5] 13, 46, 51, 97, 271 💬
1300Rosiglitazone[1] Rosiglitazone[2] Rosiglitazone maleate ,
Rosiglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[7] 46, 57, 75, 77, 97, 222, 265 💬
1301Rosiglitazone (Avandia)[1] Rosiglitazone[2] Rosiglitazone maleate ,
Rosiglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 222 💬
1302Rosiglitazone Extended Release Tablets[1] Rosiglitazone[2] Rosiglitazone maleate ,
Rosiglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 46 💬
1303Rosiglitazone maleate[1] Rosiglitazone[2] Rosiglitazone maleate ,
Rosiglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[3] 46, 75, 265 💬
1304Rosiglitazone therapy[1] Rosiglitazone[2] Rosiglitazone maleate ,
Rosiglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 57 💬
1305Rosiglitazone XR[1] Rosiglitazone[2] Rosiglitazone maleate ,
Rosiglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 46 💬
1306Rosnilimab[1] Rosnilimab[1] Rosnilimab 💬 [1] PDCD1 💬 [3] Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[2] 46, 97 💬
1307Rosuvastatin[1] Rosuvastatin[2] Rosuvastatin calcium ,
Rosuvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[16] 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
1308Rosuvastatin + BCX7353[1] Rosuvastatin[2] Rosuvastatin calcium ,
Rosuvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 65 💬
1309Rosuvastatin 10 mg[1] Rosuvastatin[2] Rosuvastatin calcium ,
Rosuvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 96 💬
1310Rosuvastatin 10mg[1] Rosuvastatin[2] Rosuvastatin calcium ,
Rosuvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 97 💬
1311Rosuvastatin 20mg[1] Rosuvastatin[2] Rosuvastatin calcium ,
Rosuvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 79 💬
1312ROSUVASTATIN CALCIUM[2] Calcium,
Rosuvastatin		[2] Rosuvastatin calcium ,
Rosuvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[4] 49, 79, 97, 299 💬
1313Rosuvastatin calcium 40mg[2] Calcium,
Rosuvastatin		[2] Rosuvastatin calcium ,
Rosuvastatin 💬 		[1] HMGCR 💬 [3] AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬[1] 56 💬
1314Rosuvastatine EG----[1] 97 💬
1315ROT-TDS 8 mg/24 h----[1] 6 💬
1316Rotigexole 8 mg----[1] 6 💬
1317Rotigotin----[1] 6 💬
1318ROTIGOTINA[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 127 💬
1319ROTIGOTINE[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 6, 67, 127 💬
1320Rotigotine (Reference product PR 2.1.1)[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1321Rotigotine (Test product PR 2.3.1)[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1322Rotigotine 4Mg/24Hrs Patch[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 127 💬
1323Rotigotine 6Mg/24Hrs Patch[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 127 💬
1324Rotigotine 8Mg/24Hrs Patch[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1325Rotigotine hydrochloride[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1326Rotigotine Nasal Spray[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1327Rotigotine transdermal patch[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1328Rotigotine transdermal patch 2mg/24h(10cm2)[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1329Rotigotine transdermal patch 4mg/24h (20cm2)[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1330Rotigotine transdermal patch 6mg/24h (30cm2)[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1331Rotigotine transdermal patch 8mg/24h (40cm2)[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1332Rotigotine TTS (Test)[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1333Rotigotine, extended-release microspheres[1] Rotigotine[1] Rotigotine 💬 [1] DRD2 💬 [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
1334Routine drainage surgery----[1] 96 💬
1335Routine steroid administration group----[1] 85 💬
1336Routine transdermal oestrogen patch----[1] 78 💬
1337Routine Treatment----[1] 88 💬
1338Routine Treatment of CD----[1] 96 💬
1339Roxithromycin[1] Roxithromycin[1] Roxithromycin 💬 --[2] 46, 299 💬
1340Royal jelly[1] Royal jelly[1] Royal jelly 💬 --[1] 49 💬
1341ROZANOLIXIZUMAB[1] Rozanolixizumab[1] Rozanolixizumab 💬 --[3] 11, 14, 63 💬
1342RozanolixizumabProduct Code: UCB7665Pharmaceutical Form: Solution for infusionINN or Proposed INN: ROZANOLIXIZUMABCAS Number: 1584645-37-3Current Sponsor code: UCB7665Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 140-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Subcutaneous use----[1] 63 💬
1343ROZEREM----[1] 6 💬
1344Rozibafusp Alfa[1] Rozibafusp Alfa[1] Rozibafusp alfa 💬 [2] ICOSLG,
TNFSF13B 💬 		[5] Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
1345RP 103----[2] 8, 19 💬
1346RP-A501[1] RP-A501---[1] 32 💬
1347RP-L102----[1] 285 💬
1348RP-L201[1] RP-L201[1] Marnetegragene autotemcel 💬 [1] ITGB2 💬 [21] Amoebiasis, Cell adhesion molecule (CAM) interaction, Complement and coagulation cascades, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, IgSF CAM signaling, Integrin signaling, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Pertussis, Phagocytosis, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Tuberculosis, Viral myocarditis 💬[1] 65 💬
1349RP103----[2] 8, 19 💬
1350RPC-1063----[1] 13 💬
1351RPC0163----[1] 96 💬
1352RPC1063----[3] 13, 96, 97 💬
1353RPC1063 (equivalent to ozanimod[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬
1354RPC1063 (equivalent to ozanimod HCl)[1] Ozanimod[2] Ozanimod hydrochloride ,
Ozanimod 💬 		[5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[4] Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬
1355RPC4046----[1] 98 💬
1356RPH-035----[1] 13 💬
1357RPH-104----[2] 54, 266 💬
1358RPI78M for injection----[1] 20 💬
1359RPL554----[1] 299 💬
1360RPS 2505----[2] 246, 299 💬
1361RQ-00000010----[1] 6 💬
1362RR110 (Tamibarotene)[1] Tamibarotene[1] Tamibarotene 💬 [1] RARA 💬 [5] Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[1] 96 💬
1363RS-BACLOFEN[1] Baclofen[1] Baclofen 💬 [2] GABBR1,
GABBR2 💬 		[8] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 10 💬
1364RS01 dry powder inhaler (RS01 DPI)----[1] 86 💬
1365RSLV-132----[2] 49, 53 💬
1366RSN0402 Part 1----[1] 85 💬
1367RSN0402 Part 2----[1] 85 💬
1368RSP-1502----[1] 299 💬
1369RSS0343 Tabella----[1] 299 💬
1370RSS0343 Tablets----[1] 299 💬
1371RT001----[3] 2, 5, 121 💬
1372RT234 - vardenafil inhalation powder[1] Vardenafil[2] Vardenafil ,
Vardenafil hydrochloride 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[1] 86 💬
1373RTA 402----[3] 67, 86, 218 💬
1374RTL1000[1] RTL-1000---[1] 13 💬
1375RTL1000 (recombinant T cell receptor ligand)[1] RTL-1000---[1] 13 💬
1376RTNV148B IgG----[3] 46, 97, 271 💬
1377RTV----[1] 265 💬
1378RTX-134----[1] 240 💬
1379Rubidium[1] Rubidium---[2] 84, 86 💬
1380Ruconest----[1] 65 💬
1381RUCONEST - 2100 U - POLVERE PER SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 2100 U----[1] 65 💬
1382Ruconest 2100 U powder for solution for injection----[1] 65 💬
1383Ruconest®----[1] 65 💬
1384RUFINAMIDE[1] Rufinamide[1] Rufinamide 💬 [6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 144 💬
1385Rufinamide (E2080)[1] Rufinamide[1] Rufinamide 💬 [6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 144 💬
1386Rufinamide oral suspension[1] Rufinamide[1] Rufinamide 💬 [6] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		[5] Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬[1] 144 💬
1387Rugonersen[1] Rugonersen---[1] 201 💬
1388Rupatadine[1] Rupatadine[2] Rupatadine ,
Rupatadine fumarate 💬 		[2] HRH1,
PTAFR 💬 		[5] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬[2] 46, 97 💬
1389Rutin[1] Rutin[1] Rutoside 💬 --[3] 46, 97, 271 💬
1390Rutin 500 MG[1] Rutin[1] Rutoside 💬 --[1] 97 💬
1391Rutin 500 MG Oral Tablet[1] Rutin[1] Rutoside 💬 --[1] 97 💬
1392Ruxience----[1] 13 💬
1393Ruxolitinib[1] Ruxolitinib[2] Ruxolitinib ,
Ruxolitinib phosphate 💬 		[2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[7] 13, 15, 50, 60, 65, 228, 331 💬
1394Ruxolitinib (JAKAVI®)[1] Ruxolitinib[2] Ruxolitinib ,
Ruxolitinib phosphate 💬 		[2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 60 💬
1395Ruxolitinib 5 MG BID Oral Tablet[1] Ruxolitinib[2] Ruxolitinib ,
Ruxolitinib phosphate 💬 		[2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 60 💬
1396Ruxolitinib Topical Cream[1] Ruxolitinib[2] Ruxolitinib ,
Ruxolitinib phosphate 💬 		[2] JAK1,
JAK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 50 💬
1397RVA576----[3] 62, 109, 162 💬
1398RVA576 (COVERSIN)----[2] 62, 109 💬
1399RVG 03820----[1] 3 💬
1400RVG 05565----[1] 96 💬
1401RVG 07151----[1] 96 💬
1402RVG 08740----[1] 6 💬
1403RVG 08938----[1] 75 💬
1404RVG 101614----[1] 60 💬
1405RVG 104433----[1] 107 💬
1406RVG 105155----[1] 60 💬
1407RVG 114681----[2] 96, 97 💬
1408RVG 116648----[2] 96, 97 💬
1409RVG 13760----[1] 298 💬
1410RVG 15375----[1] 75 💬
1411RVG 18236----[2] 75, 227 💬
1412RVG 18388----[1] 160 💬
1413RVG 28636----[1] 107 💬
1414RVG 33865----[1] 86 💬
1415RVG 51680----[1] 14 💬
1416RVG 55618----[1] 6 💬
1417RVG 56083----[1] 14 💬
1418RVG00859----[2] 96, 97 💬
1419RVP-001----[1] 13 💬
1420RVT-101 35 mg----[1] 6 💬
1421RVT-1201----[1] 86 💬
1422RVT-1401----[3] 11, 14, 61 💬
1423RVT-1401, HL161BKN, HBM9161----[1] 11 💬
1424RVT-1601----[1] 85 💬
1425RVT-1601 (formerly, PA101B)----[1] 85 💬
1426RVT-3101----[1] 96 💬
1427RVX000222----[1] 19 💬
1428RWJ-445380 100 mg----[1] 46 💬
1429RWJ-445380 200 mg----[1] 46 💬
1430RWJ-445380 300 mg----[1] 46 💬
1431RWJ-445380 capsule 100 mg----[1] 46 💬
1432RWJ-445380 capsules 150 mg----[1] 46 💬
1433RWJ-445380 Capsules 50 mg----[1] 46 💬
1434RWJ-445380-002----[1] 46 💬
1435RXC007----[1] 85 💬
1436RXC007 20 mg Capsule----[1] 85 💬
1437RXC007 50 mg Capsule----[1] 85 💬
1438RY_SW01 cell injection----[1] 51 💬
1439RYAH-Medtech Inhaler----[5] 2, 6, 13, 96, 97 💬
1440RYR----[1] 46 💬
1441Rytary 145 mg----[1] 6 💬
1442Rytary 195 mg----[1] 6 💬
1443Répaglinide----[1] 299 💬